- رپورٹیں
- بنیادی ایڈیشن 2026
- Complete edition
Exponential Technology Report 2026: Neurotechnology and Human–Machine Interfaces
Imprint
- Editor
- Saeed Valadbaygi, Chief Steward and Managing Editor, the Global Centre for Risk and Innovation (GCRI)
- Publisher of record
- The Global Centre for Risk and Innovation (GCRI) for the Nexus Consortium, Toronto
- Report number
- NR-XTECH-NEURO-GLOBAL-2026-BASELINE
- شواہد کی آخری تاریخ
- 30 September 2026, cut DC-XTECH-NEURO-GLOBAL-2026-B0
- حیثیت
- Draft under stewardship review; not yet released
- DOI and UNI
- Issued at deposit
- لائسنس
- CC BY 4.0 for Nexus-authored text, tables and figures; third-party material keeps its own licence
- Cite as
- Valadbaygi, S. (Ed.). (2026). Exponential Technology Report 2026: Neurotechnology and Human–Machine Interfaces (Baseline Edition 2026, Report No. NR-XTECH-NEURO-GLOBAL-2026-BASELINE) [Draft under review]. The Global Centre for Risk and Innovation (GCRI). https://therisk.global/nexus-reports/editions/xt-20/
فہرست مضامین
- Neurotechnology and Human–Machine Interfaces 2026
- Executive summary
Executive summary
The edition on a few pages: the abstract, the key messages, the headline finding and what each steward reads in it.
S.1Abstract
Neurotechnology matters to the Nexus programme in two ways. It is a new class of implanted hardware, built from electrode arrays, amplifiers, radios and software decoders that need materials, power, surgeons and long-term follow-up. It is also a new source of personal data, because the signals of the nervous system can reveal intent, and sometimes inner speech. The clinical evidence is strong for single participants. A speech decoder reached 62 words per minute on a 125,000-word vocabulary1, and another reached a median of 78 words per minute2. A later study reported 97.5% accuracy beyond eight months after implantation, in one participant3. A fully implanted brain-spine interface stayed stable for over one year7, and an endovascular array recorded for one year in five participants8. Money and rules are moving. Neuralink reported five implanted participants and a USD 650 million round in 202520. China published an implementation opinion with targets for 2027 and 203016. UNESCO adopted a Recommendation on the Ethics of Neurotechnology in November 202510, Colorado extended its privacy law to neural data in 202414, and a US Senate bill would direct the FTC to study neural data11. The physical footprint, the workforce and market size are not measured on a common basis. This baseline sets out what the evidence supports and where it is thin. It forecasts no capability date and ranks no country or company.
S.2Key messages
Six readings that frame the neurotechnology baseline, and the eight questions this edition answers, each with its status and source.
In single participants, at 62 to 78 words per minute and up to 97.5% accuracy.123
Do speech interfaces work?Reported
One interface was stable over one year and an endovascular array recorded for one year.78
Can an implant last?Reported
Imagined sentences were decoded in four participants; safeguards are proposed.5
Can inner speech be read?Reported
UNESCO adopted a Recommendation; Colorado covers neural data; a US Senate bill is in committee.101411
What do the rules say?Reported
A 2021 constitutional rule and a 2023 deletion order; inferred data remain a grey zone.1718
What does Chile show?Reported
A USD 650 million company round in 2025; market size is not on a common basis.2029
What does the money look like?Reported
Not bound in this edition.9
What is the power and heat footprint?Not bound
Consumer neural data outside medical rules while clinical interfaces advance. SCN-XT20-NDT-01
What will 2027 test first?Expert input
S.3Headline finding
ReportedEQL 4NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-INF-001
Two Nature papers of August 2023 reported speech decoding at 62 and 78 words per minute in single participants with paralysis.
| Item | Bar, scaled to the largest value | قدر |
|---|---|---|
| Willett 2023, 125,000-word vocabulary | 62 | |
| Metzger 2023, median rate | 78 | |
| Natural conversation, as stated in the first paper | 160 |
Sources: Nature 620 (2023)12. The 160 figure is the approximate rate of natural conversation as stated in1.
Decoding of attempted speech into text is now fast enough to support conversation in a laboratory setting for a few people. The first study reported a 23.8% word error rate on a large vocabulary and the second a median of 25%; a later study in one participant reported 97.5% accuracy beyond eight months3. Each result rests on one participant and a research system.
S.4At a glance
S.5What each steward reads in it
GCRI · KEY T
Technical Truth
The evidence supports reading neurotechnology as clinical hardware and as a source of personal data.
GRF · KEY M
Public Meaning
For most people the neurotechnology story arrives as a headline about a brain implant or a question about mental privacy.
GRA · KEY F
Capital Meaning
Readiness implications only. Rounds are large and rest on company statements, market estimates differ widely and reimbursement is not reviewed.
NEXUS
Synthesis
Neurotechnology is well described by single results and thinly measured as a system.
S.6What this edition is, and is not
What this edition is
A baseline: the 2026 state of neurotechnology as clinical hardware and personal data and the couplings through which it carries risk into other systems. It synthesises published evidence and ranks no country, company or asset.
What it is not
Not a forecast of when any device will reach the market, a technology ranking, an endorsement of any company or an assessment of any programme. Medical-device rules, privacy law and funding are decisions of competent authorities.
What comes next
National, regional and sector evidence feeds the 2027 neurotechnology edition through the federation. Each edition reports what changed against this baseline: observations, source revisions, method changes, scenario updates and corrections.
Notes
Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references
- 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03.back
- 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03.back
- 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
- 16Ministry of Industry and Information Technology and six other bodies (eds.), Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry, MIIT (2025) No. 164, 23 July 2025, English translation by the Center for Security and Emerging Technology, 18 December 2025 (translation page read). Georgetown University, Washington. Observation year 2025. Accessed 2026-11-03.back
- 10UNESCO (ed.), Recommendation on the Ethics of Neurotechnology (page read: adopted November 2025 at the 43rd session of the General Conference; mandate entrusted by 194 Member States in 2023; the page states no neural data provisions). United Nations Educational, Scientific and Cultural Organization, Paris. Observation year 2025. Accessed 2026-11-03.back
- 14Colorado General Assembly (ed.), HB24-1058 Protect Privacy of Biological Data (bill page read: signed 17 April 2024; effective 7 August 2024). Colorado General Assembly, Denver. Observation year 2024. Accessed 2026-11-03.back
- 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03.back
- 5Kunz, E.M. et al., Inner speech in motor cortex and implications for speech neuroprostheses, Cell 188(17), 4658 to 4673, published online 14 August 2025 (reference record read: four participants). Cell Press, Cambridge MA. Observation year 2025. Accessed 2026-11-03.back
- 17Cornejo-Plaza, M.I., Cippitani, R. and Pasquino, V., Chilean Supreme Court ruling on the protection of brain activity: neurorights, personal data protection, and neurodata, Frontiers in Psychology 15, 27 February 2024 (reference record read). Frontiers Media, Lausanne. Observation year 2024. Accessed 2026-11-03.back
- 18Lee, B.H., Even Chile neurorights leave inferred mental data in a gray zone, Stanford Law School Law and Biosciences Blog, 27 April 2026 (blog page read; commentary, not a legal text). Stanford University, Stanford. Observation year 2026. Accessed 2026-11-03.back
- 29Mordor Intelligence (ed.), Brain-computer Interface Market Size and Share Analysis (report page updated 3 August 2026; USD 1.27 billion in 2025) and TechSci Research (ed.), Brain Computer Interface Market (report page, January 2026; USD 2.57 billion in 2025). Market-research pages, weak evidence; figures differ about twofold and none is used. Observation year 2025. Accessed 2026-11-05.back
- 9US Food and Drug Administration (ed.), Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation: Non-clinical Testing and Clinical Considerations, final guidance, May 2021 (guidance page read). Center for Devices and Radiological Health, Silver Spring. Observation year 2021. Accessed 2026-11-03.back
Neurotechnology is clinical hardware and a new class of personal data
Part I describes systems and their couplings. It ranks no country or operator and assesses no authority.
1.1The questions this part answers
Key questions
- Where is neurotechnology risk concentrated?
- Which couplings carry neurotechnology shocks into other systems?
- Which neurotechnology capabilities hold under compound stress?
- What must 2027 evidence measure first?
In this part
- Narrative
- Headline finding
- Lead figure
- Five footprint and governance chapters
- Twelve-domain reading
- Sector screens
- Dependency matrix
- Risk objects
- Capability ladder
- منظرنامہ
- Three lenses
- پورٹ فولیو
1.2The argument
Neurotechnology is usually discussed as a race between implant companies. The 2026 evidence reads it as two things at once: clinical hardware that must be powered, built from specialised materials and followed for years, and a source of data that can reveal intent and, in some studies, inner speech159.
The clinical evidence is strong for single participants. A speech decoder reached 62 words per minute on a 125,000-word vocabulary1, another a median of 78 words per minute2, and a later study 97.5% accuracy beyond eight months3. A brain-spine interface stayed stable for over one year7. These are results in one or a few people, not products.
The rules are being written now. UNESCO adopted a Recommendation in November 202510, Colorado covers neural data14, Chile amended its constitution and a court ordered deletion17, and a US Senate bill would direct the FTC to study neural data11. China set industrial targets for 2027 and 203016.
The physical base is the least measured part. No power or heat budget is bound here, long-term signal loss is an open problem in the literature2224, and market size estimates in trade sources differ widely29.
One participant with ALS and 256 intracortical electrodes reached high accuracy within hours of training and kept it beyond eight months. This is one person and a preprint record; the journal version is noted in the record3.
| Item | Bar, scaled to the largest value | قدر |
|---|---|---|
| Day 1, 50-word vocabulary | 99.6 | |
| Day 2, 125,000-word vocabulary | 90.2 | |
| Beyond eight months, 125,000-word vocabulary | 97.5 |
Source: as cited in the note to this figure. Year 2023.
Figure ID FIG-XTECH-NEURO-GLOBAL-2026-BASELINE-01-003
1.3The six-sector nexus: twenty couplings across five assessed sectors
The neurotechnology-centred matrix types the twenty couplings between the five core systems, read for their neurotechnology content. Strengths are Nexus estimates (ESTIMATED) from the cited evidence and analogue events; they set the graph that 2027 evidence will test.
Each line is one coupling from one sector to another, drawn by the strength the edition assigns. Strengths are Nexus estimates from the cited evidence and analogue events. Infrastructure: not assessed in this edition’s coupling matrix, so it is drawn hollow with no couplings. The hexagon is the estate doctrine: six sectors and fifteen relations.
- Strong
- معتدل
- Weak
- Not assessed in this edition
Source: this edition’s coupling matrix (Table 1.1); status Estimated. Hexagon: the estate doctrine (Signature).
| From, to | WAT | ENE | FOO | HLT | BIO |
|---|---|---|---|---|---|
| WAT پانی | · | WEAK no documented link | WEAK no documented link | WEAK no documented link | WEAK no documented link |
| ENE توانائی | WEAK no documented link | · | WEAK no documented link | WEAK clinical power supply, undocumented | WEAK no documented link |
| FOO خوراک | WEAK no documented link | WEAK no documented link | · | WEAK no documented link | WEAK no documented link |
| HLT صحت | WEAK no documented link | WEAK no documented link | WEAK no documented link | · | WEAK tissue response to implants |
| BIO حیاتیاتی تنوع | WEAK no documented link | WEAK no documented link | WEAK no documented link | WEAK electrode biocompatibility | · |
| Strength: strong, moderate or weak; a Nexus estimate (status Estimated) from cited evidence and analogue events. The scale is defined in Annex A. | |||||
Transmission paths
- 01
INF → HLT
Implanted interfaces restore communication and movement in single participants.
- 02
INF → DAT
Neural signals can carry intent and inner speech.
Reported inner speech study5
- 03
FIN → INF
Investment funds trials and manufacturing.
Reported company round20
- 04
BIO → INF
Tissue response and electrode materials limit long-term signal.
- 05
GOV → DAT
Laws and recommendations set how neural data may be used.
Notes
Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references
- 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 5Kunz, E.M. et al., Inner speech in motor cortex and implications for speech neuroprostheses, Cell 188(17), 4658 to 4673, published online 14 August 2025 (reference record read: four participants). Cell Press, Cambridge MA. Observation year 2025. Accessed 2026-11-03.back
- 9US Food and Drug Administration (ed.), Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation: Non-clinical Testing and Clinical Considerations, final guidance, May 2021 (guidance page read). Center for Devices and Radiological Health, Silver Spring. Observation year 2021. Accessed 2026-11-03.back
- 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03.back
- 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 10UNESCO (ed.), Recommendation on the Ethics of Neurotechnology (page read: adopted November 2025 at the 43rd session of the General Conference; mandate entrusted by 194 Member States in 2023; the page states no neural data provisions). United Nations Educational, Scientific and Cultural Organization, Paris. Observation year 2025. Accessed 2026-11-03.back
- 14Colorado General Assembly (ed.), HB24-1058 Protect Privacy of Biological Data (bill page read: signed 17 April 2024; effective 7 August 2024). Colorado General Assembly, Denver. Observation year 2024. Accessed 2026-11-03.back
- 17Cornejo-Plaza, M.I., Cippitani, R. and Pasquino, V., Chilean Supreme Court ruling on the protection of brain activity: neurorights, personal data protection, and neurodata, Frontiers in Psychology 15, 27 February 2024 (reference record read). Frontiers Media, Lausanne. Observation year 2024. Accessed 2026-11-03.back
- 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03.back
- 16Ministry of Industry and Information Technology and six other bodies (eds.), Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry, MIIT (2025) No. 164, 23 July 2025, English translation by the Center for Security and Emerging Technology, 18 December 2025 (translation page read). Georgetown University, Washington. Observation year 2025. Accessed 2026-11-03.back
- 22Ma, X. et al., Using adversarial networks to extend brain computer interface decoding accuracy over time, eLife 12, e84296, 2023 (reference record read). eLife Sciences, Cambridge. Observation year 2023. Accessed 2026-11-03.back
- 24Feng, Y. et al., Brain-computer interfaces: the dawn of a new era in disease treatment, Exploration 6(3), 2026 (reference record read: electrode biocompatibility and signal resolution named as challenges). Wiley, Beijing. Observation year 2026. Accessed 2026-11-03.back
- 29Mordor Intelligence (ed.), Brain-computer Interface Market Size and Share Analysis (report page updated 3 August 2026; USD 1.27 billion in 2025) and TechSci Research (ed.), Brain Computer Interface Market (report page, January 2026; USD 2.57 billion in 2025). Market-research pages, weak evidence; figures differ about twofold and none is used. Observation year 2025. Accessed 2026-11-05.back
- 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
Key findings
Twelve findings carry the neurotechnology baseline. They are grouped by coupling and never ranked. Each resolves to its source or, where Nexus analysis is involved, to its stated method.
2.1Headline finding
ReportedEQL 4NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-INF-001
Two Nature papers of August 2023 reported speech decoding at 62 and 78 words per minute in single participants with paralysis.
| Item | Bar, scaled to the largest value | قدر |
|---|---|---|
| Willett 2023, 125,000-word vocabulary | 62 | |
| Metzger 2023, median rate | 78 | |
| Natural conversation, as stated in the first paper | 160 |
Sources: Nature 620 (2023)12. The 160 figure is the approximate rate of natural conversation as stated in1.
Implication
Decoding of attempted speech into text is now fast enough to support conversation in a laboratory setting for a few people. The first study reported a 23.8% word error rate on a large vocabulary and the second a median of 25%; a later study in one participant reported 97.5% accuracy beyond eight months3. Each result rests on one participant and a research system.
What would move it
Results in more participants, peer-reviewed long-term outcomes and home use would each move this finding.
2.2بنیادی ڈھانچہ
ReportedEQL 4NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-INF-001
Two Nature papers of 2023 reported speech decoding at 62 words per minute on a 125,000-word vocabulary with a 23.8% word error rate, and at a median of 78 words per minute with a median word error rate of 25%, each in one participant.12
ReportedEQL 3NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-INF-002
A speech neuroprosthesis in one participant reached 97.5% accuracy on a 125,000-word vocabulary beyond eight months after implantation, using 256 intracortical electrodes.3
ReportedEQL 3NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-INF-004
A preprint of five participants with an endovascular 16-channel array reports movement-related signals recorded over one year, with no significant change in impedance for most channels.8
2.3صحت
ReportedEQL 4NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-HLT-003
A fully implanted brain-spine interface in one man with chronic tetraplegia stayed reliable for over one year and supported walking overground with crutches even when switched off.7
2.4نظم و نسق
ReportedEQL 4NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-GOV-005
Seven Chinese bodies led by the industry ministry issued an implementation opinion on 23 July 2025 that sets targets for 2027 and 2030, including two to three industrial cluster zones by 2027 and two to three globally influential enterprises by 2030.16
ReportedEQL 3NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-GOV-007
Colorado extended its privacy act to neural data in a bill signed on 17 April 2024 and in force on 7 August 2024; Chile amended its constitution in 2021 and its Supreme Court ordered deletion of one user headset data in August 2023.141718
ReportedEQL 4NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-GOV-008
UNESCO adopted a Recommendation on the Ethics of Neurotechnology at the 43rd session of its General Conference in November 2025, as a framework of values, principles and policy actions.10
ReportedEQL 4NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-GOV-009
The MIND Act of 2025 (S. 2925) would direct the FTC to study neural data and report to Congress within one year of enactment, and authorises USD 10 million for the study; it was referred to committee.1112
ReportedEQL 3NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-GOV-010
The FDA issued final guidance in May 2021 on non-clinical testing and study design for implanted interfaces, and a company reported in April 2025 a 510(k) clearance for a cortical-surface array for up to 30 days of implantation.915
2.5Data and digital
ReportedEQL 3NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-DAT-006
A 2025 study in four participants decoded imagined sentences in real time from motor cortex, found a separate neural dimension that distinguishes inner speech from attempted speech, and proposed methods to prevent unintended decoding of private inner speech.5
2.6مالیات
ReportedEQL 2NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-FIN-011
Neuralink stated in a blog post that five people with severe paralysis had been implanted and closed a USD 650 million round in June 2025; a registry entry for its PRIME study shows an estimated enrolment of 15 and a start date of 9 January 2024.1320
2.7Systemic
Expert inputEQL 2NRF-XTECH-NEURO-GLOBAL-2026-BASELINE-SYS-012
The leading compound pathway for 2027 testing is neural data from consumer devices sitting outside medical-device rules while clinical interfaces advance. § scenario
Notes
Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references
- 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03.back
- 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03.back
- 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 16Ministry of Industry and Information Technology and six other bodies (eds.), Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry, MIIT (2025) No. 164, 23 July 2025, English translation by the Center for Security and Emerging Technology, 18 December 2025 (translation page read). Georgetown University, Washington. Observation year 2025. Accessed 2026-11-03.back
- 14Colorado General Assembly (ed.), HB24-1058 Protect Privacy of Biological Data (bill page read: signed 17 April 2024; effective 7 August 2024). Colorado General Assembly, Denver. Observation year 2024. Accessed 2026-11-03.back
- 17Cornejo-Plaza, M.I., Cippitani, R. and Pasquino, V., Chilean Supreme Court ruling on the protection of brain activity: neurorights, personal data protection, and neurodata, Frontiers in Psychology 15, 27 February 2024 (reference record read). Frontiers Media, Lausanne. Observation year 2024. Accessed 2026-11-03.back
- 18Lee, B.H., Even Chile neurorights leave inferred mental data in a gray zone, Stanford Law School Law and Biosciences Blog, 27 April 2026 (blog page read; commentary, not a legal text). Stanford University, Stanford. Observation year 2026. Accessed 2026-11-03.back
- 10UNESCO (ed.), Recommendation on the Ethics of Neurotechnology (page read: adopted November 2025 at the 43rd session of the General Conference; mandate entrusted by 194 Member States in 2023; the page states no neural data provisions). United Nations Educational, Scientific and Cultural Organization, Paris. Observation year 2025. Accessed 2026-11-03.back
- 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03.back
- 12US Senate Committee on Commerce, Science, and Transportation (ed.), release on the introduction of the MIND Act, 24 September 2025 (release read: names Colorado, California, Montana and Connecticut as states with neural data laws). US Senate, Washington. Observation year 2025. Accessed 2026-11-03.back
- 9US Food and Drug Administration (ed.), Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation: Non-clinical Testing and Clinical Considerations, final guidance, May 2021 (guidance page read). Center for Devices and Radiological Health, Silver Spring. Observation year 2021. Accessed 2026-11-03.back
- 15Precision Neuroscience (ed.), company release on FDA 510(k) clearance of the Layer 7 Cortical Interface, 17 April 2025 (release read; vendor announcement, weak evidence: up to 30 days of implantation; 37 patients tested). Precision Neuroscience, New York. Observation year 2025. Accessed 2026-11-03.back
- 5Kunz, E.M. et al., Inner speech in motor cortex and implications for speech neuroprostheses, Cell 188(17), 4658 to 4673, published online 14 August 2025 (reference record read: four participants). Cell Press, Cambridge MA. Observation year 2025. Accessed 2026-11-03.back
- 13ClinicalTrials.gov (ed.), PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices, NCT06429735 (record read: recruiting; start 9 January 2024; estimated enrolment 15; updated January 2026; sponsor-supplied entry). National Library of Medicine, Bethesda. Observation year 2026. Accessed 2026-11-03.back
- 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
Systems and sectors at baseline
3.1Where each system stood at evidence close
INF · Hardware
Large-vocabulary speech decoding rate
62words per minuteone participant, 125,000-word vocabulary.
Reported2023Nature1
INF · Accuracy
Speech decoder accuracy beyond eight months
97.5%one participant; preprint record, journal version noted.
Reported2023preprint3
HLT · Clinic
Participants in the one-year endovascular study
5participants16-channel array; preprint, not peer reviewed.
Reported2025preprint8
FIN · Finance
Neuralink funding round
650USD millioncompany blog as reported by a trade outlet; vendor statement.
Reported2025trade report20
GOV · Governance
States named by Senate sponsors as having neural data laws
4statesColorado, California, Montana and Connecticut, as named.
Reported2025Senate release12
SYS · Cross-system
Estimated enrolment in the PRIME feasibility study
15participantsregistry estimate; study recruiting.
Reported2026registry13
3.2Domain posture
Each of the twelve coupled domains is read through neurotechnology, in words, not scored. The coupling column names the dependency that carries neurotechnology risk into each domain.
| دائرہ | Posture at baseline | باہمی ربط | حیثیت |
|---|---|---|---|
| WAT | Cooling water is not a documented coupling for implanted devices. | none documented | Expert input EQL 1 |
| ENE | Implant power and charging budgets are not bound in this edition. | ENE → INF | Expert input EQL 1 |
| FOO | No documented coupling at baseline. | none documented | Expert input EQL 1 |
| HLT | Clinical results in paralysis and spinal injury; benefit shown in single participants. | INF → HLT | Reported EQL 4 |
| BIO | Biocompatibility of electrodes limits long-term use; no failure rate is bound. | BIO ↔ INF | Reported EQL 3 |
| CLI | No documented coupling at baseline. | none documented | Expert input EQL 1 |
| INF | The core system: speech, spinal and endovascular interfaces working in single participants. | the core system | Reported EQL 4 |
| FIN | A USD 650 million company round in 2025; market size not on a common basis. | FIN → INF | Reported EQL 2 |
| DAT | Neural data raise privacy questions; inner speech was decoded in four participants. | INF → DAT | Reported EQL 3 |
| AIC | Trained decoders turn signals into text and speech; decoder drift is studied. | INF ↔ AIC | Reported EQL 3 |
| MIN | Electrode materials are named in the literature; no mineral dependence is bound. | MIN → INF | Inferred EQL 2 |
| TRD | Industrial policy targets name electrodes and chips; trade exposure is not bound. | TRD ↔ INF | Inferred EQL 2 |
3.3Sector screens
All sixteen sectors are screened for their dependence on neurotechnology, on the same grammar as every national edition. The evidence column describes coverage of the baseline evidence, not the performance of the sector.
| کوڈ | شعبہ | Baseline evidence | Exposure to watch | Evidence coverage |
|---|---|---|---|---|
| GS-00 | Cross-system | neurotechnology couples to health, data and materials | consumer data outside medical rules | THIN |
| GS-01 | پانی | no documented coupling | none documented | THIN |
| GS-02 | توانائی | implant power not bound | none documented | THIN |
| GS-03 | خوراک | no documented coupling | none documented | THIN |
| GS-04 | صحت | clinical results in paralysis17 | access and follow-up | PARTIAL |
| GS-05 | مالیات | USD 650 million company round20 | claims ahead of evidence | THIN |
| GS-06 | ترقی | access to implants and skilled teams | widening gaps | THIN |
| GS-07 | آب و ہوا | no documented coupling | none documented | THIN |
| GS-08 | Disaster | no documented coupling | none documented | THIN |
| GS-09 | بنیادی ڈھانچہ | clinical sites and surgical capacity | few implanting centres | THIN |
| GS-10 | شہر | no documented coupling | none documented | THIN |
| GS-11 | حیاتیاتی تنوع | no documented coupling | none documented | THIN |
| GS-12 | زمین کا مشاہدہ | no documented coupling | none documented | THIN |
| GS-13 | Cyber and digital | neural data and inner speech decoding5 | security of implants and data | PARTIAL |
| GS-14 | پالیسی | UNESCO, US bills, state laws, Chile10111417 | fragmented rules | PARTIAL |
| GS-15 | Science | strong peer-reviewed base127 | long-term outcomes | GOOD |
Notes
Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references
- 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03.back
- 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03.back
- 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
- 12US Senate Committee on Commerce, Science, and Transportation (ed.), release on the introduction of the MIND Act, 24 September 2025 (release read: names Colorado, California, Montana and Connecticut as states with neural data laws). US Senate, Washington. Observation year 2025. Accessed 2026-11-03.back
- 13ClinicalTrials.gov (ed.), PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices, NCT06429735 (record read: recruiting; start 9 January 2024; estimated enrolment 15; updated January 2026; sponsor-supplied entry). National Library of Medicine, Bethesda. Observation year 2026. Accessed 2026-11-03.back
- 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 5Kunz, E.M. et al., Inner speech in motor cortex and implications for speech neuroprostheses, Cell 188(17), 4658 to 4673, published online 14 August 2025 (reference record read: four participants). Cell Press, Cambridge MA. Observation year 2025. Accessed 2026-11-03.back
- 10UNESCO (ed.), Recommendation on the Ethics of Neurotechnology (page read: adopted November 2025 at the 43rd session of the General Conference; mandate entrusted by 194 Member States in 2023; the page states no neural data provisions). United Nations Educational, Scientific and Cultural Organization, Paris. Observation year 2025. Accessed 2026-11-03.back
- 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03.back
- 14Colorado General Assembly (ed.), HB24-1058 Protect Privacy of Biological Data (bill page read: signed 17 April 2024; effective 7 August 2024). Colorado General Assembly, Denver. Observation year 2024. Accessed 2026-11-03.back
- 17Cornejo-Plaza, M.I., Cippitani, R. and Pasquino, V., Chilean Supreme Court ruling on the protection of brain activity: neurorights, personal data protection, and neurodata, Frontiers in Psychology 15, 27 February 2024 (reference record read). Frontiers Media, Lausanne. Observation year 2024. Accessed 2026-11-03.back
- 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
Risks and capability
Four neurotechnology risk objects open the portfolio. Order carries no rank. Each is read across driver, exposure, vulnerability, capacity, cascade and consequence.
4.1Risk objects
Each risk is read across the chain from hazard to consequence, with its status and evidence-quality level.
InferredEQL 3RSK-XT20-DAT-001
Neural data outside medical and privacy rules
- Driver
- consumer headsets and decoders that infer mental states518
- زد
- users of consumer devices; participants in speech trials
- کمزوری
- inferred data fall in a grey zone in Chile18; US rules differ by state1412
- استعداد
- UNESCO Recommendation; state laws; a Senate study bill101411
- سلسلہ وار اثر
- DAT → FIN, HLT, GOV
- Horizon
- 1 to 5 years
InferredEQL 3RSK-XT20-INF-002
Long-term signal loss and device failure
InferredEQL 3RSK-XT20-GOV-003
Fragmented rules and uneven access
Expert inputEQL 2RSK-XT20-FIN-004
Company claims ahead of peer-reviewed evidence
4.2Capability ladder
Existence is not readiness. Each of the fifteen capability functions is placed on the ladder by the strongest public evidence for neurotechnology at the global level.
| Function | Rung | سطح | Strongest public evidence at baseline |
|---|---|---|---|
| Prevention and mitigation | EXISTS | FDA guidance on testing implanted interfaces; UNESCO Recommendation910 | |
| Monitoring and observation | LISTED | no common tracker of device failure or neural data practices | |
| Early warning | LISTED | no consolidated signal system | |
| Preparedness and planning | EXISTS | registry entries, policy targets and a Senate study bill111316 | |
| Redundancy and reserves | LISTED | support continuity if a device company ceases is not documented | |
| ردعمل | LISTED | no tested response to a data incident or device recall at scale | |
| Continuity of critical services | LISTED | long-term follow-up and device support not reported | |
| Recovery | LISTED | not applicable at baseline | |
| Adaptation | EXISTS | decoder recalibration and drift-correction methods studied22 | |
| Social protection | LISTED | access to implants for those who need them is not documented | |
| مالیات اور بیمہ | LISTED | reimbursement not reviewed; private rounds large20 | |
| Institutional coordination | EXISTS | UNESCO, OECD and national policies101631 | |
| Technical infrastructure | EXISTS | clinical trial sites and a cleared cortical-surface array815 | |
| Workforce | LISTED | surgeons and programming staff; no figure bound | |
| Research capacity | ADEQUATE | strong peer-reviewed base1257 | |
| A capability listed in policy is not a tested one; each rung is the strongest public evidence at baseline. | |||
Notes
Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references
- 5Kunz, E.M. et al., Inner speech in motor cortex and implications for speech neuroprostheses, Cell 188(17), 4658 to 4673, published online 14 August 2025 (reference record read: four participants). Cell Press, Cambridge MA. Observation year 2025. Accessed 2026-11-03.back
- 18Lee, B.H., Even Chile neurorights leave inferred mental data in a gray zone, Stanford Law School Law and Biosciences Blog, 27 April 2026 (blog page read; commentary, not a legal text). Stanford University, Stanford. Observation year 2026. Accessed 2026-11-03.back
- 14Colorado General Assembly (ed.), HB24-1058 Protect Privacy of Biological Data (bill page read: signed 17 April 2024; effective 7 August 2024). Colorado General Assembly, Denver. Observation year 2024. Accessed 2026-11-03.back
- 12US Senate Committee on Commerce, Science, and Transportation (ed.), release on the introduction of the MIND Act, 24 September 2025 (release read: names Colorado, California, Montana and Connecticut as states with neural data laws). US Senate, Washington. Observation year 2025. Accessed 2026-11-03.back
- 10UNESCO (ed.), Recommendation on the Ethics of Neurotechnology (page read: adopted November 2025 at the 43rd session of the General Conference; mandate entrusted by 194 Member States in 2023; the page states no neural data provisions). United Nations Educational, Scientific and Cultural Organization, Paris. Observation year 2025. Accessed 2026-11-03.back
- 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03.back
- 22Ma, X. et al., Using adversarial networks to extend brain computer interface decoding accuracy over time, eLife 12, e84296, 2023 (reference record read). eLife Sciences, Cambridge. Observation year 2023. Accessed 2026-11-03.back
- 24Feng, Y. et al., Brain-computer interfaces: the dawn of a new era in disease treatment, Exploration 6(3), 2026 (reference record read: electrode biocompatibility and signal resolution named as challenges). Wiley, Beijing. Observation year 2026. Accessed 2026-11-03.back
- 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03.back
- 9US Food and Drug Administration (ed.), Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation: Non-clinical Testing and Clinical Considerations, final guidance, May 2021 (guidance page read). Center for Devices and Radiological Health, Silver Spring. Observation year 2021. Accessed 2026-11-03.back
- 15Precision Neuroscience (ed.), company release on FDA 510(k) clearance of the Layer 7 Cortical Interface, 17 April 2025 (release read; vendor announcement, weak evidence: up to 30 days of implantation; 37 patients tested). Precision Neuroscience, New York. Observation year 2025. Accessed 2026-11-03.back
- 16Ministry of Industry and Information Technology and six other bodies (eds.), Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry, MIIT (2025) No. 164, 23 July 2025, English translation by the Center for Security and Emerging Technology, 18 December 2025 (translation page read). Georgetown University, Washington. Observation year 2025. Accessed 2026-11-03.back
- 40ISO (ed.), ISO 14708-3:2017 Implants for surgery, Active implantable medical devices, Part 3: Implantable neurostimulators (ISO open-data deliverables record: published 12 April 2017; current, confirmed). International Organization for Standardization, Geneva. Observation year 2017. Accessed 2026-11-05.back
- 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
- 27Paradromics (ed.), Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus Brain-Computer Interface (company release of November 2025, read as reposted by BioSpace; IDE approval for an early feasibility study that will initially enrol two participants at three sites). Company statement, weak evidence. Paradromics, Austin. Observation year 2025. Accessed 2026-11-05.back
- 30Synchron (ed.), Synchron Raises USD 200 Million Series D to Advance Brain-Computer Interface Technology (Business Wire release as reproduced by I-Connect007, 7 November 2025; total funding USD 345 million). Company statement, weak evidence; no figure used. Synchron, New York. Observation year 2025. Accessed 2026-11-05.back
- 13ClinicalTrials.gov (ed.), PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices, NCT06429735 (record read: recruiting; start 9 January 2024; estimated enrolment 15; updated January 2026; sponsor-supplied entry). National Library of Medicine, Bethesda. Observation year 2026. Accessed 2026-11-03.back
- 31OECD (ed.), Recommendation of the Council on Responsible Innovation in Neurotechnology, OECD/LEGAL/0457, adopted 11 December 2019 (instrument text opened). Organisation for Economic Co-operation and Development, Paris. Observation year 2019. Accessed 2026-11-05.back
- 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
Consumer neural data outside medical rules
A conditional statement under stated assumptions, never a prediction.
5.1مفروضات
Scenario SCN-XT20-NDT-01: what is assumed, and what is held constant.
- بنیادی حوالہ
- the 2026 reference state in this edition
- Drivers
- consumer neural devices spread faster than rules, while decoders improve at inferring intent
- Analogues
- the 2023 Chilean deletion order and the 2024 Colorado law1417
- Interventions
- none modelled: the specification describes the unmitigated case
- Run state
- narrative specification; quantified run scheduled for 2027
5.2The cascade, step by step
- 1
INF → DAT
decoders reach inner speech in research settings
2025
- 2
DAT → GOV
states and bodies add neural data to privacy law
2024
- 3
GOV → FIN
companies face rules that differ by jurisdiction
2025
- 4
FIN → INF
funding favours clinical devices with clear pathways
2025
- 5
DAT → HLT
consumer devices that infer mood or intent fall outside medical oversight
2024
- 6
GOV → DAT
a federal study reports on gaps in existing law
2025
5.3The scenario as a table of steps
How the shock in scenario SCN-XT20-NDT-01 would travel through Neurotechnology and Human–Machine Interfaces’s coupled systems, step by step, under the assumptions the edition states.
| مرحلہ | What happens | ماخذ |
|---|---|---|
| 01 Infrastructure to dat | Decoders reach inner speech in research settings. Analogue or source: 2025. | Edition XT-20, scenario SCN-XT20-NDT-01, step 1 |
| 02 DAT to governance | States and bodies add neural data to privacy law. Analogue or source: 2024. | Edition XT-20, scenario SCN-XT20-NDT-01, step 2 |
| 03 Governance to finance | Companies face rules that differ by jurisdiction. Analogue or source: 2025. | Edition XT-20, scenario SCN-XT20-NDT-01, step 3 |
| 04 Finance to infrastructure | Funding favours clinical devices with clear pathways. Analogue or source: 2025. | Edition XT-20, scenario SCN-XT20-NDT-01, step 4 |
| 05 DAT to health | Consumer devices that infer mood or intent fall outside medical oversight. Analogue or source: 2024. | Edition XT-20, scenario SCN-XT20-NDT-01, step 5 |
| 06 Governance to dat | A federal study reports on gaps in existing law. Analogue or source: 2025. | Edition XT-20, scenario SCN-XT20-NDT-01, step 6 |
A teaching model of a conditional scenario under the edition’s stated assumptions: not a forecast, not a prediction and not a warning. Sources: Neurotechnology and Human–Machine Interfaces 2026, scenario SCN-XT20-NDT-01 (2026); Neurotechnology and Human–Machine Interfaces 2026, references (NR-CIT-1) (2026).
Notes
Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references
- 14Colorado General Assembly (ed.), HB24-1058 Protect Privacy of Biological Data (bill page read: signed 17 April 2024; effective 7 August 2024). Colorado General Assembly, Denver. Observation year 2024. Accessed 2026-11-03.back
- 17Cornejo-Plaza, M.I., Cippitani, R. and Pasquino, V., Chilean Supreme Court ruling on the protection of brain activity: neurorights, personal data protection, and neurodata, Frontiers in Psychology 15, 27 February 2024 (reference record read). Frontiers Media, Lausanne. Observation year 2024. Accessed 2026-11-03.back
Readings from the other desks
The neurotechnology baseline is read through each steward’s lens, then once as a whole. Each lens is a projection of reviewed findings, not a separate argument. The other desks’ own editions of this subject are listed first, as cross-references, not copies.
6.1The other desks’ editions of this subject
Federation: each desk writes its own edition for the subjects in its remit. Until a desk releases, its edition shows its frame and the reading this edition printed for it.
| Desk | ایڈیشن | ریاست | Identifier |
|---|---|---|---|
| GCRI Systems Evidence | Systems Evidence: Neurotechnology and Human–Machine Interfaces 2026 | Drafted, in stewardship review | NR-XTECH-NEURO-GLOBAL-2026-BASELINE-v1.0.0 |
| GRF Public Deliberation | Outside this desk’s remit | Not in remit | |
| GRA Capital Readiness | Outside this desk’s remit | Not in remit | |
| Standards Progress | Standards Progress: Neurotechnology and Human–Machine Interfaces 2026 | In preparation | NR-NXS-XT-20-2026-BASELINE (reserved) |
| Academy Capability | Capability: Neurotechnology and Human–Machine Interfaces 2026 | In preparation | NR-RA-XT-20-2026-BASELINE (reserved) |
| Index Measurement | Outside this desk’s remit | Not in remit |
6.2Three lenses
One edition, read by each steward. The lens of this site comes first.
GCRI · KEY T
Technical Truth
The evidence supports reading neurotechnology as clinical hardware and as a source of personal data. Clinical results are real in single participants, rules are being written, and the footprint, workforce and market are not measured on a common basis. Evidence is strongest for single studies and weakest for durability, power and market size.
INF-001 · DAT-006 · GOV-008 · SYS-012
GRF · KEY M
Public Meaning
For most people the neurotechnology story arrives as a headline about a brain implant or a question about mental privacy. The baseline asks that public debate separate peer-reviewed results from company statements, and keep the protection of neural data in view.
DAT-006 · GOV-007 · FIN-011
GRA · KEY F
Capital Meaning
Readiness implications only. Rounds are large and rest on company statements, market estimates differ widely and reimbursement is not reviewed2029. These show where finance-readiness evidence will matter. Nothing here is advice, a rating or an authorisation.
FIN-011 · GOV-010
NEXUS
Synthesis
Neurotechnology is well described by single results and thinly measured as a system. The 2027 programme should map neural data rules, publish comparable durability and power figures and test the consumer data pathway.
SYS-012 · N-01 · N-02
6.3Standards, Academy and steward contributions
How the Nexus Standards drafts, the Risk Academy and the three stewards feed each quarterly edition for neurotechnology. The standards are a preparatory working draft (2026) and are cited as drafts, never as adopted standards.
| Quarter | ایڈیشن | سوال | حد |
|---|---|---|---|
| Q1 | State and Agenda | What matters this year, and what is the starting position? | observed baseline stays distinct from planned work |
| Q2 | Evidence and Build | What new evidence and capability exist? | a configured capability is not a validated result |
| Q3 | Stress Test and Readiness | What do scenarios and tests show? | simulated loss or performance is not observed impact |
| Q4 | Annual Synthesis and Renewal | What changed in the year, and what renews? | release follows review, not event publicity deadlines |
| Steward or body | کردار | Contribution route |
|---|---|---|
| GCRI Canada | Lead Institution and Consortium Secretariat; publisher of record; technical truth (key T) | science and practice communities · GCRI gateway |
| Global Risks Forum (GRF) | leadership, dialogue and the Universe programme; public meaning (key M) | policy, Universe and national adoption · GRF gateway |
| Global Risks Alliance (GRA) | finance, insurance and development readiness; capital meaning (key F) | finance and insurance · GRA gateway |
| Nexus Standards | preparatory drafts on vocabulary, hazards, indicators and methods | Standards site · working groups HAZ, IND, MTH, FIN, AI |
| Risk Academy | learning pathways tied to the agenda questions | Academy gateway · learning by review |
| Nexus Standards and Academy | technology chapter inputs: GCRI evidence, NXS standards, RA capability | technology editorial board |
Standards drafts used in this edition
- Risk vocabulary NRS-C1 (424 terms) for terms in the glossary
- Hazard atlas NHS-1 1.1.0 (905 hazards in 120 families) for risk objects
- Seven risk classes: global, catastrophic, existential, emerging, planetary, exponential, frontier-tech
Standards calendar to watch
- Founding calls from 20 October 2026; working groups meet from 5 November 2026
- Inaugural Global Standards Council session, 12 January 2027
- Quarterly reviews in March, June, September and December, aligned with each edition
6.4GCRI reading: the model card
GCRI’s reading of this edition is its model card: what the national model is, what it computes and where it stops. It is printed in full in Annex A, with the methods it belongs to. Annex A, methodology
6.5Global Risks Forum reading: editorial essays
Four signed essays by the Reports editorial team set out the positions this edition takes. They are interpretation, labelled as such; the evidence they draw on is in the findings register.
Neurotechnology is a clinical build-out and a new kind of personal data. The first is slow, surgical and material. The second is a policy question that exists now. Keeping them apart avoids both hype and complacency.
EDITORIAL ESSAY · 01
Two stories, one technology
A peer-reviewed paper, a registry entry and a company announcement carry different weight. This edition labels each, and asks for a common basis before outcomes are compared.
EDITORIAL ESSAY · 02
Separate results, registries and claims
Power, heat, materials and surgical teams are rarely counted. A published footprint would show whether scale is limited by physics, supply or skills.
EDITORIAL ESSAY · 03
The footprint is the blind spot
Laws on neural data are being passed while the technology is at feasibility stage. The question is whether they reach inferred data and consumer devices.
EDITORIAL ESSAY · 04
Rules arrive before evidence
6.6Global Risks Alliance reading: 2027 neurotechnology readiness pack
The registers that open the 2027 global cycle. At baseline each is initialised from this edition.
| Item | رجسٹر | State at baseline | First 2027 entry |
|---|---|---|---|
| E1 | Neurotechnology risk state delta | baseline set by this edition | changes against the baseline |
| E2 | WEFH+B state delta | five global system readings set | indicator updates and freshness |
| E3 | Agenda and Portfolio movement | eight agenda items · 6 proposed objects | admission decisions |
| E4 | Federation delivery register | national chapters in preparation | national chapters |
| E5 | Consortium capability register | national consortia forming | first contributions |
| E6 | Leadership questions and challenges | none yet | first challenge log |
| E7 | Foundry technical state | national environments prepared | first federation cut |
| E8 | Publication candidates | twelve findings carried forward | PUBLISH · HOLD dispositions |
| E9 | Universe readiness | one candidate mission | admission and role spine |
| E10 | Correction register | none | first federation-wide cycle |
Publication dispositions
- شائع کریں
- Hold
- Needs evidence
- Restricted
- منسوخ شدہ
6.7Nexus Standards reading: standards and regulatory watch
Instruments and published guidance that shape the systems in this edition, by status on the retrieval date. The edition assesses no one’s compliance.
- IN FORCE
- PUBLISHED
- BILL
- PUBLISHED · VOLUNTARY
| دستاویز | ادارہ | دائرہ کار | حیثیت | Relevance |
|---|---|---|---|---|
| FDA guidance on implanted brain-computer interfaces9 | US FDA | US | PUBLISHED 2021 | non-clinical testing and study design |
| UNESCO Recommendation on the Ethics of Neurotechnology10 | UNESCO General Conference | global | ADOPTED NOVEMBER 2025 | ethics framework |
| MIND Act, S. 292511 | US Senate | US | BILL · IN COMMITTEE | federal neural data study |
| Colorado HB24-105814 | Colorado | Colorado | IN FORCE 2024 | neural data in privacy act |
| California SB 122325 | California | California | IN FORCE 2025 | neural data as sensitive data |
| Montana and Connecticut neural data laws41 | state legislatures | US states | ENACTED 2025 | neural data |
| Chile constitutional amendment, Law 21.38342 | چلی | چلی | IN FORCE 2021 | brain activity protection |
| OECD Recommendation on Responsible Innovation in Neurotechnology31 | OECD | OECD members | PUBLISHED 2019 | principles |
| EU Medical Device Regulation, Annex XVI39 | یورپی یونین | EU | IN FORCE | brain stimulation equipment |
| ISO 14708-340 | ISO | global | PUBLISHED · VOLUNTARY | implantable neurostimulators |
Changed since 2024
6.8Risk Academy reading: literature and evidence review, science and assessments
The review behind this edition covers neurotechnology assessments, peer-reviewed science and the institutional reports that bind its findings. Systematic reviews for each agenda item begin in 2027.
Review protocol
- سوال
- What does the published evidence establish about neurotechnology as clinical hardware and personal data and its couplings?
- Sources searched
- peer-reviewed journals and preprints; guidance, laws and recommendations; policy translations; company and trade reports
- Window
- releases available at evidence close, 30 September 2026
- Selection
- sources that bind or contextualise a finding in this edition
- Next step
- systematic reviews for agenda items 01 to 05 in 2027
| حوالہ | قسم | سال | کردار | Used for |
|---|---|---|---|---|
| Willett et al.1 | journal article | 2023 | supports | speech decoding |
| Metzger et al.2 | journal article | 2023 | supports | speech and avatar |
| Card et al.3 | preprint record | 2023 | supports | accuracy over time |
| Wairagkar et al.4 | preprint record | 2024 | context | voice synthesis |
| Kunz et al.5 | journal article | 2025 | supports | inner speech |
| Willett et al.6 | journal article | 2021 | context | handwriting decoding |
| Lorach et al.7 | journal article | 2023 | supports | brain-spine interface |
| Chetty et al.8 | preprint | 2025 | supports | endovascular stability |
| حوالہ | Issuer | سال | کردار | Used for |
|---|---|---|---|---|
| Ma et al.22 | journal article | 2023 | supports | decoder drift |
| Wellman et al.23 | journal article | 2018 | context | electrode materials |
| Feng et al.24 | journal article | 2026 | context | biocompatibility review |
| Bublitz et al.21 | journal article | 2025 | context | moratorium proposal |
| Szoszkiewicz and Yuste19 | journal article | 2025 | context | mental privacy |
| Hochberg et al.36 | journal article | 2006 | framework | early implanted interface |
| Collinger et al.37 | journal article | 2013 | context | arm control |
| Moses et al.38 | journal article | 2021 | context | speech decoding |
| Yuste et al.34 | journal article | 2017 | framework | ethical priorities |
| Ienca and Andorno35 | journal article | 2017 | framework | new rights |
| حوالہ | Issuer | سال | کردار | Used for |
|---|---|---|---|---|
| FDA guidance on implanted interfaces9 | FDA | 2021 | supports | testing and study design |
| UNESCO Recommendation page10 | UNESCO | 2025 | supports | global ethics |
| MIND Act text11 | US Senate | 2025 | supports | federal study bill |
| Colorado HB24-105814 | Colorado legislature | 2024 | supports | state law |
| Chinese implementation opinion16 | seven Chinese bodies, translated | 2025 | supports | industrial targets |
| حوالہ | Issuer | سال | کردار | Used for |
|---|---|---|---|---|
| Cleared cortical-surface array15 | Precision Neuroscience | 2025 | context | vendor release |
| Neuralink funding report20 | trade outlet | 2025 | context | vendor statement |
| Neurotechnology reports29 | market-research firms | 2025 | context | market size, weak |
| Synchron Series D release30 | company release | 2025 | context | vendor statements |
| Consumer neurotechnology report33 | Neurorights Foundation | 2024 | context | privacy practices |
Where the evidence agrees
Notes
Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references
- 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
- 29Mordor Intelligence (ed.), Brain-computer Interface Market Size and Share Analysis (report page updated 3 August 2026; USD 1.27 billion in 2025) and TechSci Research (ed.), Brain Computer Interface Market (report page, January 2026; USD 2.57 billion in 2025). Market-research pages, weak evidence; figures differ about twofold and none is used. Observation year 2025. Accessed 2026-11-05.back
- 9US Food and Drug Administration (ed.), Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation: Non-clinical Testing and Clinical Considerations, final guidance, May 2021 (guidance page read). Center for Devices and Radiological Health, Silver Spring. Observation year 2021. Accessed 2026-11-03.back
- 10UNESCO (ed.), Recommendation on the Ethics of Neurotechnology (page read: adopted November 2025 at the 43rd session of the General Conference; mandate entrusted by 194 Member States in 2023; the page states no neural data provisions). United Nations Educational, Scientific and Cultural Organization, Paris. Observation year 2025. Accessed 2026-11-03.back
- 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03.back
- 14Colorado General Assembly (ed.), HB24-1058 Protect Privacy of Biological Data (bill page read: signed 17 April 2024; effective 7 August 2024). Colorado General Assembly, Denver. Observation year 2024. Accessed 2026-11-03.back
- 25California Legislature (ed.), SB 1223 (Becker), Consumer privacy: sensitive personal information: neural data, Chapter 887, Statutes of 2024, chaptered 28 September 2024 (bill record read on CalMatters Digital Democracy; sponsor release of 27 September 2024: signed by the Governor, in effect 1 January 2025; the legislature page returned an access error). California Legislature, Sacramento. Observation year 2024. Accessed 2026-11-05.back
- 41Spivack, J. and Victory, C., State Neural Data Laws, Summer 2025 (Future of Privacy Forum chart, August 2025; Montana SB 163 adds neurotechnology data to the Genetic Information Privacy Act, effective 1 October 2025; Connecticut SB 1295 adds neural data to sensitive data under its data privacy act, most sections effective 1 July 2026). Secondary compilation; the state texts were not opened. Future of Privacy Forum, Washington. Observation year 2025. Accessed 2026-11-05.back
- 42Carey (ed.), Ley N 21.383: publican reforma constitucional para establecer el desarrollo cientifico y tecnologico al servicio de las personas (client alert, 3 November 2021; Law 21.383 published in the Diario Oficial on 25 October 2021; adds a final paragraph to Article 19 No. 1 on protecting brain activity and the information derived from it). Law firm summary; the official text page did not load. Carey, Santiago. Observation year 2021. Accessed 2026-11-05.back
- 31OECD (ed.), Recommendation of the Council on Responsible Innovation in Neurotechnology, OECD/LEGAL/0457, adopted 11 December 2019 (instrument text opened). Organisation for Economic Co-operation and Development, Paris. Observation year 2019. Accessed 2026-11-05.back
- 39European Parliament and Council, Regulation (EU) 2017/745 of 5 April 2017 on medical devices, Annex XVI point 6 (equipment intended for brain stimulation that applies electrical currents or magnetic or electromagnetic fields that penetrate the cranium). Official Journal of the European Union L 117, 5 May 2017, Luxembourg. Observation year 2017. Accessed 2026-11-05.back
- 40ISO (ed.), ISO 14708-3:2017 Implants for surgery, Active implantable medical devices, Part 3: Implantable neurostimulators (ISO open-data deliverables record: published 12 April 2017; current, confirmed). International Organization for Standardization, Geneva. Observation year 2017. Accessed 2026-11-05.back
- 12US Senate Committee on Commerce, Science, and Transportation (ed.), release on the introduction of the MIND Act, 24 September 2025 (release read: names Colorado, California, Montana and Connecticut as states with neural data laws). US Senate, Washington. Observation year 2025. Accessed 2026-11-03.back
- 16Ministry of Industry and Information Technology and six other bodies (eds.), Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry, MIIT (2025) No. 164, 23 July 2025, English translation by the Center for Security and Emerging Technology, 18 December 2025 (translation page read). Georgetown University, Washington. Observation year 2025. Accessed 2026-11-03.back
- 18Lee, B.H., Even Chile neurorights leave inferred mental data in a gray zone, Stanford Law School Law and Biosciences Blog, 27 April 2026 (blog page read; commentary, not a legal text). Stanford University, Stanford. Observation year 2026. Accessed 2026-11-03.back
- 43European Parliament and Council, Regulation (EU) 2024/1689 of 13 June 2024 laying down harmonised rules on artificial intelligence (Artificial Intelligence Act), Article 5(1)(f) on AI systems to infer emotions in the workplace and education institutions, except for medical or safety reasons. Official Journal of the European Union, L series, 12 July 2024, Luxembourg. Observation year 2024. Accessed 2026-11-05.back
- 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03.back
- 4Wairagkar, M. et al., An instantaneous voice synthesis neuroprosthesis, bioRxiv preprint, 19 August 2024 (preprint record read: 256 microelectrodes, one participant with ALS; no quantitative scores in the abstract; the record notes Nature 644(8075), 145 to 152, 2025). Cold Spring Harbor Laboratory, New York. Observation year 2024. Accessed 2026-11-03.back
- 5Kunz, E.M. et al., Inner speech in motor cortex and implications for speech neuroprostheses, Cell 188(17), 4658 to 4673, published online 14 August 2025 (reference record read: four participants). Cell Press, Cambridge MA. Observation year 2025. Accessed 2026-11-03.back
- 6Willett, F.R., Avansino, D.T., Hochberg, L.R., Henderson, J.M. and Shenoy, K.V., High-performance brain-to-text communication via handwriting, Nature 593(7858), 249 to 254, published online 12 May 2021 (reference record read: 90 characters per minute; 94.1% raw online accuracy). Springer Nature, London. Observation year 2021. Accessed 2026-11-03.back
- 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03.back
- 22Ma, X. et al., Using adversarial networks to extend brain computer interface decoding accuracy over time, eLife 12, e84296, 2023 (reference record read). eLife Sciences, Cambridge. Observation year 2023. Accessed 2026-11-03.back
- 23Wellman, S.M. et al., A materials roadmap to functional neural interface design, Advanced Functional Materials 28(12), 2018 (reference record read; no figures in the abstract). Wiley, Weinheim. Observation year 2018. Accessed 2026-11-03.back
- 24Feng, Y. et al., Brain-computer interfaces: the dawn of a new era in disease treatment, Exploration 6(3), 2026 (reference record read: electrode biocompatibility and signal resolution named as challenges). Wiley, Beijing. Observation year 2026. Accessed 2026-11-03.back
- 21Bublitz, C. et al., A moratorium on implantable non-medical neurotech until effects on the mind are properly understood, Neuroethics 18(3), article 46, 2025 (reference record read: proposes a mental impact assessment, a moratorium and a ban for children). Springer, Dordrecht. Observation year 2025. Accessed 2026-11-03.back
- 19Szoszkiewicz, L. and Yuste, R., Mental privacy: navigating risks, rights and regulation, EMBO Reports 26(14), 3469 to 3473, published online 25 June 2025 (reference record read; no abstract beyond the subtitle). Springer Nature, London. Observation year 2025. Accessed 2026-11-03.back
- 36Hochberg, L.R. et al., Neuronal ensemble control of prosthetic devices by a human with tetraplegia, Nature 442, 164 to 171, 2006 (Crossref record). Springer Nature, London. Observation year 2006. Accessed 2026-11-05.back
- 37Collinger, J.L. et al., High-performance neuroprosthetic control by an individual with tetraplegia, The Lancet 381, 557 to 564, 2013 (Crossref record). Elsevier, London. Observation year 2013. Accessed 2026-11-05.back
- 38Moses, D.A. et al., Neuroprosthesis for decoding speech in a paralyzed person with anarthria, New England Journal of Medicine 385, 217 to 227, 2021 (Crossref record). Massachusetts Medical Society, Waltham. Observation year 2021. Accessed 2026-11-05.back
- 34Yuste, R. et al., Four ethical priorities for neurotechnologies and AI, Nature 551, 159 to 163, 2017 (Crossref record). Springer Nature, London. Observation year 2017. Accessed 2026-11-05.back
- 35Ienca, M. and Andorno, R., Towards new human rights in the age of neuroscience and neurotechnology, Life Sciences, Society and Policy 13, 5, 2017 (Crossref record). Springer, Berlin. Observation year 2017. Accessed 2026-11-05.back
- 15Precision Neuroscience (ed.), company release on FDA 510(k) clearance of the Layer 7 Cortical Interface, 17 April 2025 (release read; vendor announcement, weak evidence: up to 30 days of implantation; 37 patients tested). Precision Neuroscience, New York. Observation year 2025. Accessed 2026-11-03.back
- 30Synchron (ed.), Synchron Raises USD 200 Million Series D to Advance Brain-Computer Interface Technology (Business Wire release as reproduced by I-Connect007, 7 November 2025; total funding USD 345 million). Company statement, weak evidence; no figure used. Synchron, New York. Observation year 2025. Accessed 2026-11-05.back
- 33Genser, J., Damianos, S. and Yuste, R., Safeguarding Brain Data: Assessing the Privacy Practices of Consumer Neurotechnology Companies (report for the Neurorights Foundation, April 2024; policy documents of 30 companies reviewed; no figure used). Neurorights Foundation, New York. Observation year 2024. Accessed 2026-11-05.back
The 2027 agenda
Eight bounded questions open the 2027 neurotechnology agenda. Each comes from a baseline finding, names the initiative that will carry it and the first output due in the 2027 neurotechnology edition.
7.1Questions for the operational series
- N-01
Where does neural data from consumer devices sit outside medical-device and privacy rules, and which laws reach inferred data?
INI-XT20-NDT-01 · neural data map; first output: jurisdiction overlay.
- N-02
What power and heat budgets do implanted interfaces work within, and how do they limit channel counts?
INI-XT20-PWR-02 · power and heat footprint; first output: budget table by platform.
- N-03
Which materials and fabrication steps are single points of failure for electrodes and implants?
INI-XT20-MAT-03 · materials and fabrication; first output: dependence map.
- N-04
How can long-term device failure and signal loss be reported on a common basis?
INI-XT20-DUR-04 · durability on a common basis; first output: failure table.
- N-05
How can trial outcomes and company claims be compared on a common basis?
INI-XT20-CLM-05 · claims on a common basis; first output: claims table.
- N-06
Which national rules cover neural data, and how do they differ?
To be admitted in 2027; first output: rule overlay.
- N-07
What clinical workforce exists for implantation, programming and follow-up?
To be admitted in 2027; first output: scoping note.
- N-08
Which readiness capabilities have been tested in real cases, and which are only planned?
Readiness capability register; first output: rung evidence for 15 functions.
7.2Portfolio proposed for the Q1 2027 alignment
Five initiatives and one Universe mission candidate are proposed for the 2027 neurotechnology portfolio. They are programme objects: no partner, funder or member is attached to them in this edition.
| ID | Object | Kind | سوال | ریاست |
|---|---|---|---|---|
| INI-XT20-NDT-01 | Neural data map | Initiative | N-01 | مجوزہ |
| INI-XT20-PWR-02 | Power and heat footprint | Initiative | N-02 | مجوزہ |
| INI-XT20-MAT-03 | Materials and fabrication | Initiative | N-03 | مجوزہ |
| INI-XT20-DUR-04 | Durability on a common basis | Initiative | N-04 | مجوزہ |
| INI-XT20-CLM-05 | Claims on a common basis | Initiative | N-05 | مجوزہ |
| MSN-XT20-2027-01 | Consumer neural data Universe mission | مشن | N-01 | Candidate |
7.3The pathway
The neurotechnology edition reads national readiness chapters, the coupled sector reports on health and cyber systems, and the global edition through one governed evidence graph. At baseline the federation is designed; the global health and cyber editions are drafted. This page states what exists today and what comes next.
- 01
National readiness chapters
neurotechnology and neural data readiness in each national edition
IN PREPARATION · national baselines
- 02
Sector couplings
GS-04 health · GS-13 cyber and digital · XT-10 cryptography
GS-04 DRAFTED · sector baselines
- 03
Technology system model
devices, power, materials, workforce, governance
v0 SPECIFIED · v1 with federation evidence
- 04
Strategic links
SR-02 lifeline systems · SR-13 strategic technology
PLANNED · strategic baselines
- 05
Universe
annual proving environment
CANDIDATE MISSION · mandate in 2027
- 06
XT-20 report
this series
BASELINE DRAFT · 2027 annual edition
- 07
Evidence and correction
one graph, many projections
OPEN · first correction cycle in 2027
7.4Universe 2027: evidence pack for the neurotechnology candidate mission
- 01
اختیار
- 02
Core Build · 1 month
- 03
Action · 1 week
- 04
Evidence seal
- 05
Portfolio correction
- 06
Next mandate
| Item | ریکارڈ | ریاست | Timing |
|---|---|---|---|
| F1 | Annual mandate record | PLANNED | after the Q2 2027 alignment |
| F2 | Core Build record | PLANNED | one month before the exercise |
| F3 | مشق کے شواہد | PLANNED | during the Action week |
| F4 | Decision packets | PLANNED | exercise state only |
| F5 | Proof receipts | PLANNED | scoped to each recorded check |
| F6 | After-action report | PLANNED | within one quarter |
| F7 | Upgrade docket | PLANNED | routed to the Portfolio |
| F8 | Portfolio renewal | PLANNED | 2027 global annual edition |
| F9 | Public synthesis | PLANNED | public-safe extracts only |
مشن
- ID
- MSN-XT20-2027-01 · Consumer neural data Universe mission
- Role spine
- Leadership sponsor · Institutional anchor · Mission lead: drawn from national pathways
- Receiving actors
- to be identified with the mandate
7.5Handoffs and routing
Where the baseline’s findings go next. A handoff routes a finding for awareness, review or work; it transfers no authority.
| Finding | Routed to | مقصد | Class |
|---|---|---|---|
| INF-001 · speech decoding | INI-XT20-CLM-05 | claims on a common basis | PUBLIC |
| INF-002 · accuracy over time | INI-XT20-DUR-04 | durability on a common basis | PUBLIC |
| DAT-006 · inner speech | INI-XT20-NDT-01 | neural data map | PUBLIC |
| GOV-007 · state and Chilean law | INI-XT20-NDT-01 | neural data map | PUBLIC |
| GOV-009 · MIND Act | regional consortia | rule overlay | PUBLIC |
| GOV-010 · guidance and clearance | INI-XT20-PWR-02 · key F review | power and heat footprint | PUBLIC |
| FIN-011 · funding and enrolment | INI-XT20-MAT-03 | materials and fabrication | PUBLIC |
| SYS-012 · compound pathway | MSN-XT20-2027-01 | Universe candidate | CONSORTIUM |
| Class | Where it goes | Who can see it |
|---|---|---|
| PUBLIC | the published edition and its evidence bundle | anyone |
| CONSORTIUM | governed rooms of the federation | consortium members under agreement |
| CONTROLLED | need-to-know channels | named competent actors only |
7.6Feeds and signal register
| Feed | Producer | Latency | Feeds into |
|---|---|---|---|
| Preprint servers and journals on interface results | peer review and preprints | continuous | INF-001 |
| ClinicalTrials.gov entries for implanted interface studies | registry | per update | FIN-011 |
| FDA guidance and clearance announcements | US FDA and companies | per release | GOV-010 |
| State and federal neural data bills | legislatures | per session | GOV-009 |
| UNESCO and OECD neurotechnology pages | intergovernmental bodies | per release | GOV-008 |
| Chinese industrial policy texts | ministries | per release | GOV-005 |
| Company announcements and funding reports | companies and trade press | per event | FIN-011 |
Escalation routes
- none · keep monitoring
- research question
- project
- risk object
- annual publication
- signal report
| ID | Signal | Corroboration | نظام | راستہ |
|---|---|---|---|---|
| SIG-XT20-001 | Inner speech decoded in four participants5 | CORROBORATED | INF · DAT | research question N-01 |
| SIG-XT20-002 | UNESCO Recommendation adopted in November 202510 | CORROBORATED | GOV | initiative N-01 |
| SIG-XT20-003 | Company statements on participants and clearance1520 | PARTIAL | FIN · INF | research question N-05 |
Notes
Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references
- 5Kunz, E.M. et al., Inner speech in motor cortex and implications for speech neuroprostheses, Cell 188(17), 4658 to 4673, published online 14 August 2025 (reference record read: four participants). Cell Press, Cambridge MA. Observation year 2025. Accessed 2026-11-03.back
- 10UNESCO (ed.), Recommendation on the Ethics of Neurotechnology (page read: adopted November 2025 at the 43rd session of the General Conference; mandate entrusted by 194 Member States in 2023; the page states no neural data provisions). United Nations Educational, Scientific and Cultural Organization, Paris. Observation year 2025. Accessed 2026-11-03.back
- 15Precision Neuroscience (ed.), company release on FDA 510(k) clearance of the Layer 7 Cortical Interface, 17 April 2025 (release read; vendor announcement, weak evidence: up to 30 days of implantation; 37 patients tested). Precision Neuroscience, New York. Observation year 2025. Accessed 2026-11-03.back
- 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
Systems in depth
One section per system: its state at evidence close, its exposures and what the operational series will watch.
8.1Interface hardware and decoding platforms
Interfaces record from implanted electrodes, from the brain surface or from inside a blood vessel, and decode with trained models. Evidence is strongest where peer review exists, and weakest where claims rest on company statements.
| جزو | ریاست | شواہد | حیثیت |
|---|---|---|---|
| Intracortical arrays | speech decoded at 62 to 78 words per minute and 97.5% accuracy beyond eight months in single participants | 12346 | رپورٹ شدہ |
| Endovascular arrays | five participants recorded for one year, preprint | 8 | رپورٹ شدہ |
| Cortical-surface arrays | a company reported clearance for up to 30 days; another reported an IDE for a two-participant early feasibility study in 2025, from company material | 1527 | رپورٹ شدہ |
| Closed-loop stimulation and wearables | an adaptive deep brain stimulation system was approved in 2025 per the company; a wearable wrist interface paper appeared in 2025; a visual prosthesis designation of 2024 is a company statement reported by trade press | 283244 | Inferred |
Couplings
- INF → HLT clinical benefit
- INF → DAT neural signals as data
- BIO ↔ INF tissue response
Evidence to bind in 2027
- claims on a common basis
- participants beyond single studies
Related editions
- GLB Global Systems
- GS-04 Health and One Health
- GS-13 Cyber and Digital Systems
- XT-10 Cybersecurity and Advanced Cryptography
- XT-12 Advanced Materials and Nanotechnology
- XT-01 Artificial Intelligence and Agentic Systems
8.2Power, heat and data of implants
An implant must be powered, kept cool enough for tissue and moved off the body as data. No power or heat budget was bound in this edition.
| جزو | ریاست | شواہد | حیثیت |
|---|---|---|---|
| Power and charging | no budget bound; guidance asks for non-clinical testing of implanted interfaces | 9 | NOT BOUND |
| حرارت | no limit or measurement bound; an implantable neurostimulator standard exists | 40 | NOT BOUND |
| Data volume and radio links | channel counts known for two studies; data rates not bound | 38 | Inferred |
| Cooling water | no documented coupling | 9 | Expert input |
Couplings
- ENE → INF implant power
- INF → BIO heat and tissue
- INF → DAT data off the body
Evidence to bind in 2027
- power and heat budgets by platform
- data rates and radio limits
Related editions
- GLB Global Systems
- GS-04 Health and One Health
- GS-13 Cyber and Digital Systems
- XT-10 Cybersecurity and Advanced Cryptography
- XT-12 Advanced Materials and Nanotechnology
- XT-01 Artificial Intelligence and Agentic Systems
8.3Materials, durability and fabrication
Electrodes sit in tissue for years. Signal loss, drift and biocompatibility are open problems in the literature, and fabrication dependence is not bound here.
| جزو | ریاست | شواہد | حیثیت |
|---|---|---|---|
| Electrode materials | a materials roadmap for neural interfaces exists | 23 | رپورٹ شدہ |
| Biocompatibility | long-term biocompatibility and signal resolution remain to be improved | 24 | رپورٹ شدہ |
| Decoder drift | accuracy falls as neurons turn over; methods correct for it | 22 | رپورٹ شدہ |
| Fabrication | capacity by country not bound; policy targets name electrodes and chips | 16 | Inferred |
Couplings
- BIO ↔ INF biocompatibility
- MIN → INF materials
- TRD → INF industrial policy
Evidence to bind in 2027
- device failure rates
- materials dependence by platform
Related editions
- GLB Global Systems
- GS-04 Health and One Health
- GS-13 Cyber and Digital Systems
- XT-10 Cybersecurity and Advanced Cryptography
- XT-12 Advanced Materials and Nanotechnology
- XT-01 Artificial Intelligence and Agentic Systems
8.4Economy, investment and workforce
Company rounds are large and rest on company statements. Market size depends on definition, and workforce numbers are not bound.
| جزو | ریاست | شواہد | حیثیت |
|---|---|---|---|
| Company funding | a USD 650 million round in June 2025 with a press-reported pre-money valuation of about USD 9 billion; another company reported a Series D round in November 2025 | 2030 | رپورٹ شدہ |
| Trial scale | registry estimate of 15; company statement of 5 in June 2025; a company statement of 21 in January 2026 as reported by a news agency | 132026 | رپورٹ شدہ |
| Market size | trade sources differ widely by definition; none bound | 29 | NOT BOUND |
| Industry policy | two to three cluster zones by 2027 and two to three leading enterprises by 2030 | 16 | رپورٹ شدہ |
Couplings
- FIN → INF scale-up
- GOV → FIN industrial policy
- HLT → INF clinical workforce
Evidence to bind in 2027
- market size on a common definition
- workforce size and skills gaps
Related editions
- GLB Global Systems
- GS-04 Health and One Health
- GS-13 Cyber and Digital Systems
- XT-10 Cybersecurity and Advanced Cryptography
- XT-12 Advanced Materials and Nanotechnology
- XT-01 Artificial Intelligence and Agentic Systems
8.5Neural data, security and governance watch
The nearest effect of neurotechnology on other systems is on privacy law. Rules differ by place, and several apply only to data used for identification.
| جزو | ریاست | شواہد | حیثیت |
|---|---|---|---|
| Global ethics | UNESCO Recommendation adopted November 2025; OECD Recommendation of December 2019 | 1031 | رپورٹ شدہ |
| United States federal | FDA guidance of 2021; MIND Act bill in committee | 91112 | رپورٹ شدہ |
| United States states | Colorado in force 7 August 2024; California in force 1 January 2025 per the sponsor; Montana from 1 October 2025 and Connecticut mostly from 1 July 2026 per a privacy forum tracker | 142541 | رپورٹ شدہ |
| Chile and others | constitutional rule, 2023 deletion order, pending neurorights bill; inferred data a grey zone; EU device and AI rules | 1718423943 | رپورٹ شدہ |
| Advocacy and ethics | proposals for a moratorium on non-medical implants and a mental privacy framework; a 2024 consumer report on 30 companies | 1921333435 | رپورٹ شدہ |
Couplings
- INF → DAT neural data
- GOV → DAT rules
- GOV → FIN compliance cost
Evidence to bind in 2027
- text of national laws
- consumer practices by company
Related editions
- GLB Global Systems
- GS-04 Health and One Health
- GS-13 Cyber and Digital Systems
- XT-10 Cybersecurity and Advanced Cryptography
- XT-12 Advanced Materials and Nanotechnology
- XT-01 Artificial Intelligence and Agentic Systems
Notes
Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references
- 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03.back
- 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03.back
- 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 4Wairagkar, M. et al., An instantaneous voice synthesis neuroprosthesis, bioRxiv preprint, 19 August 2024 (preprint record read: 256 microelectrodes, one participant with ALS; no quantitative scores in the abstract; the record notes Nature 644(8075), 145 to 152, 2025). Cold Spring Harbor Laboratory, New York. Observation year 2024. Accessed 2026-11-03.back
- 6Willett, F.R., Avansino, D.T., Hochberg, L.R., Henderson, J.M. and Shenoy, K.V., High-performance brain-to-text communication via handwriting, Nature 593(7858), 249 to 254, published online 12 May 2021 (reference record read: 90 characters per minute; 94.1% raw online accuracy). Springer Nature, London. Observation year 2021. Accessed 2026-11-03.back
- 15Precision Neuroscience (ed.), company release on FDA 510(k) clearance of the Layer 7 Cortical Interface, 17 April 2025 (release read; vendor announcement, weak evidence: up to 30 days of implantation; 37 patients tested). Precision Neuroscience, New York. Observation year 2025. Accessed 2026-11-03.back
- 27Paradromics (ed.), Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus Brain-Computer Interface (company release of November 2025, read as reposted by BioSpace; IDE approval for an early feasibility study that will initially enrol two participants at three sites). Company statement, weak evidence. Paradromics, Austin. Observation year 2025. Accessed 2026-11-05.back
- 28Medtronic (ed.), Medtronic receives FDA approval for BrainSense Adaptive DBS technology (company release republished by News-Medical, 3 March 2025; FDA approval of adaptive deep brain stimulation and the BrainSense Electrode Identifier for Parkinson disease). Company statement, weak evidence. Medtronic, Dublin. Observation year 2025. Accessed 2026-11-05.back
- 32Kaifosh, P., Reardon, T.R. and CTRL-labs at Reality Labs, A generic non-invasive neuromotor interface for human-computer interaction, Nature 645, 702 to 711, 2025 (Crossref record). Springer Nature, London. Observation year 2025. Accessed 2026-11-05.back
- 44Holt, K., Neuralink says the FDA designated its Blindsight implant as a breakthrough device (Engadget, 18 September 2024; company statement as reported). Trade press reporting a vendor announcement, weak evidence. Engadget, New York. Observation year 2024. Accessed 2026-11-05.back
- 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03.back
- 9US Food and Drug Administration (ed.), Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation: Non-clinical Testing and Clinical Considerations, final guidance, May 2021 (guidance page read). Center for Devices and Radiological Health, Silver Spring. Observation year 2021. Accessed 2026-11-03.back
- 40ISO (ed.), ISO 14708-3:2017 Implants for surgery, Active implantable medical devices, Part 3: Implantable neurostimulators (ISO open-data deliverables record: published 12 April 2017; current, confirmed). International Organization for Standardization, Geneva. Observation year 2017. Accessed 2026-11-05.back
- 23Wellman, S.M. et al., A materials roadmap to functional neural interface design, Advanced Functional Materials 28(12), 2018 (reference record read; no figures in the abstract). Wiley, Weinheim. Observation year 2018. Accessed 2026-11-03.back
- 24Feng, Y. et al., Brain-computer interfaces: the dawn of a new era in disease treatment, Exploration 6(3), 2026 (reference record read: electrode biocompatibility and signal resolution named as challenges). Wiley, Beijing. Observation year 2026. Accessed 2026-11-03.back
- 22Ma, X. et al., Using adversarial networks to extend brain computer interface decoding accuracy over time, eLife 12, e84296, 2023 (reference record read). eLife Sciences, Cambridge. Observation year 2023. Accessed 2026-11-03.back
- 16Ministry of Industry and Information Technology and six other bodies (eds.), Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry, MIIT (2025) No. 164, 23 July 2025, English translation by the Center for Security and Emerging Technology, 18 December 2025 (translation page read). Georgetown University, Washington. Observation year 2025. Accessed 2026-11-03.back
- 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
- 13ClinicalTrials.gov (ed.), PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices, NCT06429735 (record read: recruiting; start 9 January 2024; estimated enrolment 15; updated January 2026; sponsor-supplied entry). National Library of Medicine, Bethesda. Observation year 2026. Accessed 2026-11-03.back
- 30Synchron (ed.), Synchron Raises USD 200 Million Series D to Advance Brain-Computer Interface Technology (Business Wire release as reproduced by I-Connect007, 7 November 2025; total funding USD 345 million). Company statement, weak evidence; no figure used. Synchron, New York. Observation year 2025. Accessed 2026-11-05.back
- 26Santhosh, C., Elon Musk’s Neuralink says it has 21 participants enrolled in trials (Reuters, 28 January 2026, read as published by The Star; company statement of 21 participants enrolled worldwide, up from 12 in September 2025). News agency report of a company statement, weak evidence. Reuters, London. Observation year 2026. Accessed 2026-11-05.back
- 29Mordor Intelligence (ed.), Brain-computer Interface Market Size and Share Analysis (report page updated 3 August 2026; USD 1.27 billion in 2025) and TechSci Research (ed.), Brain Computer Interface Market (report page, January 2026; USD 2.57 billion in 2025). Market-research pages, weak evidence; figures differ about twofold and none is used. Observation year 2025. Accessed 2026-11-05.back
- 12US Senate Committee on Commerce, Science, and Transportation (ed.), release on the introduction of the MIND Act, 24 September 2025 (release read: names Colorado, California, Montana and Connecticut as states with neural data laws). US Senate, Washington. Observation year 2025. Accessed 2026-11-03.back
- 10UNESCO (ed.), Recommendation on the Ethics of Neurotechnology (page read: adopted November 2025 at the 43rd session of the General Conference; mandate entrusted by 194 Member States in 2023; the page states no neural data provisions). United Nations Educational, Scientific and Cultural Organization, Paris. Observation year 2025. Accessed 2026-11-03.back
- 17Cornejo-Plaza, M.I., Cippitani, R. and Pasquino, V., Chilean Supreme Court ruling on the protection of brain activity: neurorights, personal data protection, and neurodata, Frontiers in Psychology 15, 27 February 2024 (reference record read). Frontiers Media, Lausanne. Observation year 2024. Accessed 2026-11-03.back
- 18Lee, B.H., Even Chile neurorights leave inferred mental data in a gray zone, Stanford Law School Law and Biosciences Blog, 27 April 2026 (blog page read; commentary, not a legal text). Stanford University, Stanford. Observation year 2026. Accessed 2026-11-03.back
- 31OECD (ed.), Recommendation of the Council on Responsible Innovation in Neurotechnology, OECD/LEGAL/0457, adopted 11 December 2019 (instrument text opened). Organisation for Economic Co-operation and Development, Paris. Observation year 2019. Accessed 2026-11-05.back
- 14Colorado General Assembly (ed.), HB24-1058 Protect Privacy of Biological Data (bill page read: signed 17 April 2024; effective 7 August 2024). Colorado General Assembly, Denver. Observation year 2024. Accessed 2026-11-03.back
- 25California Legislature (ed.), SB 1223 (Becker), Consumer privacy: sensitive personal information: neural data, Chapter 887, Statutes of 2024, chaptered 28 September 2024 (bill record read on CalMatters Digital Democracy; sponsor release of 27 September 2024: signed by the Governor, in effect 1 January 2025; the legislature page returned an access error). California Legislature, Sacramento. Observation year 2024. Accessed 2026-11-05.back
- 41Spivack, J. and Victory, C., State Neural Data Laws, Summer 2025 (Future of Privacy Forum chart, August 2025; Montana SB 163 adds neurotechnology data to the Genetic Information Privacy Act, effective 1 October 2025; Connecticut SB 1295 adds neural data to sensitive data under its data privacy act, most sections effective 1 July 2026). Secondary compilation; the state texts were not opened. Future of Privacy Forum, Washington. Observation year 2025. Accessed 2026-11-05.back
- 42Carey (ed.), Ley N 21.383: publican reforma constitucional para establecer el desarrollo cientifico y tecnologico al servicio de las personas (client alert, 3 November 2021; Law 21.383 published in the Diario Oficial on 25 October 2021; adds a final paragraph to Article 19 No. 1 on protecting brain activity and the information derived from it). Law firm summary; the official text page did not load. Carey, Santiago. Observation year 2021. Accessed 2026-11-05.back
- 39European Parliament and Council, Regulation (EU) 2017/745 of 5 April 2017 on medical devices, Annex XVI point 6 (equipment intended for brain stimulation that applies electrical currents or magnetic or electromagnetic fields that penetrate the cranium). Official Journal of the European Union L 117, 5 May 2017, Luxembourg. Observation year 2017. Accessed 2026-11-05.back
- 43European Parliament and Council, Regulation (EU) 2024/1689 of 13 June 2024 laying down harmonised rules on artificial intelligence (Artificial Intelligence Act), Article 5(1)(f) on AI systems to infer emotions in the workplace and education institutions, except for medical or safety reasons. Official Journal of the European Union, L series, 12 July 2024, Luxembourg. Observation year 2024. Accessed 2026-11-05.back
- 19Szoszkiewicz, L. and Yuste, R., Mental privacy: navigating risks, rights and regulation, EMBO Reports 26(14), 3469 to 3473, published online 25 June 2025 (reference record read; no abstract beyond the subtitle). Springer Nature, London. Observation year 2025. Accessed 2026-11-03.back
- 21Bublitz, C. et al., A moratorium on implantable non-medical neurotech until effects on the mind are properly understood, Neuroethics 18(3), article 46, 2025 (reference record read: proposes a mental impact assessment, a moratorium and a ban for children). Springer, Dordrecht. Observation year 2025. Accessed 2026-11-03.back
- 33Genser, J., Damianos, S. and Yuste, R., Safeguarding Brain Data: Assessing the Privacy Practices of Consumer Neurotechnology Companies (report for the Neurorights Foundation, April 2024; policy documents of 30 companies reviewed; no figure used). Neurorights Foundation, New York. Observation year 2024. Accessed 2026-11-05.back
- 34Yuste, R. et al., Four ethical priorities for neurotechnologies and AI, Nature 551, 159 to 163, 2017 (Crossref record). Springer Nature, London. Observation year 2017. Accessed 2026-11-05.back
- 35Ienca, M. and Andorno, R., Towards new human rights in the age of neuroscience and neurotechnology, Life Sciences, Society and Policy 13, 5, 2017 (Crossref record). Springer, Berlin. Observation year 2017. Accessed 2026-11-05.back
طریقۂ کار
How the edition was made: methods, the model card, the evidence cut and its age, the acceptance record and the glossary.
A.1طریقے
The global baseline uses published values and four simple derivations. Each is shown in full so that any reader can reproduce it.
| No. | Derivation | Calculation | نتیجہ |
|---|---|---|---|
| (1) | Ratio of median rate in2 to rate in1 | 78 ÷ 62 | about 1.3 times |
| (2) | Gap between1 and natural conversation as stated in1 | 160 ÷ 62 | about 2.6 times |
| (3) | Months from preprint to journal version of the accuracy study3 | December 2023 to August 2024 | 8 months |
| (4) | Share of the 2025 round in the reported pre-money valuation20 | 650 ÷ 9,000 | about 7% |
| Strength | تعریف |
|---|---|
| STRONG | a disruption in the source system has historically changed the target system’s service or output within one season, in more than one region |
| MODERATE | an effect is documented but buffered or slower |
| WEAK | an effect is plausible but not documented at global scale |
| لیبل | Rule |
|---|---|
| رپورٹ شدہ | value as issued by its source, with year |
| Inferred | reasoned from cited evidence; never a measurement |
| تخمینی | Nexus analytical value with stated method |
| منظرنامہ | conditional on stated assumptions |
| Expert input | structured editorial judgement awaiting evidence |
A.2Model card, Neurotechnology System Model v0
- Model ID
- MDL-XT20-NEURO · v0.1
- مقصد
- represent neurotechnology as clinical hardware and a source of neural data coupled to health, materials, finance, workforce and privacy
- خاندان
- graph-based system of systems
- Inputs
- the cited sources of this edition; no proprietary data
- طریقہ
- expert-specified coupling strengths (STRONG · MODERATE · WEAK) from assessments and analogue events
- توثیق
- none yet, first validation against federation evidence in 2027
- غیر یقینی صورتحال
- qualitative; strengths are hypotheses, not measurements
- Domain of validity
- global scale; not for asset-, site- or country-level use
- Reproducibility
- strength table and sources published in this edition
typed in v0
documented within one season
documented, buffered
plausible, undocumented
A.3The baseline evidence cut
Every Nexus edition is published from a frozen evidence cut. The global baseline cut is documentary: it pins the exact edition of every source cited. Federation cuts begin with the first national Foundry cuts in 2027.
- Cut ID
- DC-XTECH-NEURO-GLOBAL-2026-B0
- قسم
- baseline documentary cut
- Resolution policy
- pinned · as of 30 September 2026
- Sources pinned
- 44 cited sources, each at the edition and access date in the references
- Model runs
- none at baseline, analytical values are stated with their method
- Digest
- computed at freeze and recorded in the publication record
- Supersedes
- nothing, first cut of the series
- Superseded by
- the 2027 neurotechnology annual cut
نسب
- 01
source edition
- 02
pinned citation
- 03
finding
- 04
page
- 05
publication record
| Element | Baseline 2026 | 2027 global annual |
|---|---|---|
| ماخذات | cited global publications, pinned by edition | national, regional and sector cuts through one graph |
| Analysis | stated methods and editorial estimates | typed analysis specifications |
| Models | Neurotechnology System Model v0 specification | model runs with receipts |
| Findings | twelve baseline findings | findings re-bound to federation evidence |
| جائزہ | five passes scheduled | five passes on the exact digest |
A.4Evidence age and coverage
A 2026 global edition rests on evidence observed in many different years. This page shows each time base, so that no single year label hides older evidence.
| Indicator | مشاہدہ شدہ | Released | Cadence | Next release |
|---|---|---|---|---|
| Speech decoding papers | 2023 | Aug 2023 | one-off | follow-up papers |
| Speech accuracy over time | 2023 preprint · 2024 journal | Dec 2023 · Aug 2024 | one-off | more participants |
| Brain-spine interface | 2023 | May 2023 | one-off | longer follow-up |
| Endovascular study | 2025 | Sep 2025 | one-off | peer-reviewed version |
| PRIME registry entry | 2026 | Jan 2026 | continuous | next update |
| US neural data bill | 2025 | Sep 2025 | per session | committee action |
| UNESCO Recommendation | 2025 | Nov 2025 | one-off | national uptake |
| Chinese implementation opinion | 2025 | Jul 2025 | periodic | 2027 milestones |
| نظام | احاطہ | Thinnest dimension |
|---|---|---|
| Hardware | PARTIAL | failure rates on a common basis |
| Clinic | PARTIAL | outcomes beyond one year |
| Neural data | PARTIAL | consumer practices |
| نظم و نسق | PARTIAL | text of national laws |
| Investment | THIN | market size and public funding |
| Energy and heat | THIN | power and heat budgets |
| Skills | THIN | workforce numbers |
| Materials | THIN | dependence by platform |
| خانہ | Source that would fill it | Blocker |
|---|---|---|
| Power and heat budgets of implanted interfaces | device makers, regulators, peer-reviewed engineering papers | no figure retrieved; the search for heating and power limits returned no quantitative source |
| Market size on a common definition | industry statistics and audited company reports29 | two market-research pages give USD 1.27 and 2.57 billion for 2025; none is bound |
| Clinical workforce for implantation, programming and follow-up | national statistics, professional bodies | not retrieved; capability rung stays LISTED |
| Long-term failure and explant rates across platforms | trial reports, registries, manufacturers | only one-year results read78; no common reporting |
| Number of participants implanted per company | company reports and registry updates132026 | company statement of 5 in June 2025; a company statement of 21 in January 2026 was reported by a news agency26 |
| Peer-reviewed results for company-announced devices | journals for each company claim1527 | company releases only; no paper located |
| Consumer neural data practices by company | regulators, advocacy and academic audits33 | report read; no figure used |
| Text of California, Montana and Connecticut neural data laws | state legislature sites2541 | California chaptering record and sponsor release read; Montana and Connecticut read in a privacy forum tracker; bill texts not opened |
| Public funding totals for neurotechnology programmes | ministries, research councils | the national research programme budget page returned an access error |
| Electrode materials and fabrication dependence by platform | industry and trade statistics | only a 2018 materials roadmap abstract read23 |
| Status of the MIND Act after referral to committee | congressional record | status read from bill text and a release only |
| Reimbursement and access to implants by country | health ministries, insurers | not reviewed |
| Wearable and non-invasive interface deployment data | companies, regulators | one peer-reviewed paper32; no deployment figure |
| Capability rungs beyond guidance and planning | agencies, hospitals, laboratories | not reviewed |
A.5Evidence cards, two anchor sources
Published in Nature 620 (2023) by a Stanford-led group. One-off study. Role: binds INF-001 and the speech tiles. Coverage: one participant with ALS and four intracortical arrays.
EVD-XT20-001
A high-performance speech neuroprosthesis1
Introduced in the US Senate in 2025 as S. 2925. One-off text. Role: binds GOV-009. Coverage: US federal study of neural data; status was committee referral.
EVD-XT20-002
MIND Act of 2025 bill text11
| Dimension | EVD-XT20-001 | EVD-XT20-002 |
|---|---|---|
| Completeness | one participant; 50-word and 125,000-word vocabularies | full bill text; later status not read |
| Timeliness | published online 23 August 2023 | introduced 2025 |
| Revision | single paper version | amendments possible in committee |
| Method transparency | methods and data in the paper | text public |
| External validation | peer review | legislative process |
Evidence cards to follow in 2027
A.6Publication acceptance record
Editorial self-check at evidence close. Every applicable item carries a disposition; the remaining items are review, approval and deposit.
| گروپ | رقبہ | Items | Pass | N/A | Pending |
|---|---|---|---|---|---|
| D1 | Identity and scope | 8 | 8 | 0 | 0 |
| D2 | Source and data | 12 | 9 | 1 | 2 |
| D3 | Analysis and models | 12 | 3 | 8 | 1 |
| D4 | Findings and claims | 9 | 8 | 0 | 1 |
| D5 | Figures, tables, maps | 10 | 6 | 2 | 2 |
| D6 | Editorial and citations | 10 | 8 | 0 | 2 |
| D7 | Review and approval | 13 | 0 | 0 | 13 |
| D8 | Artefact and design | 12 | 7 | 0 | 5 |
| D9 | Registry and release | 9 | 0 | 0 | 9 |
Publication gate
- Conditions met
- 14 of 23 at evidence close
- Blocking problems
- none recorded
- Open conditions
- reviews, approval of the exact digest, deposit, registry pointer
Not applicable at baseline
- Model runs
- first runs in Q1 2027
- نقشے
- plates in Q2 2027
- Waivers
- none
A.7Status words
| حیثیت | اس کا کیا مطلب ہے |
|---|---|
| مشاہدہ شدہ | Measured directly and published by the source. |
| رپورٹ شدہ | Published statistics of an official or institutional source. |
| Declared | Stated by the body concerned; not independently measured. |
| تخمینی | A Nexus estimate from cited evidence, with its method in Annex A. |
| ماڈل شدہ | Produced by a stated model from cited inputs. |
| Inferred | Reasoned from cited evidence; not measured. |
| Forecast | A projection by the cited source. |
| Simulated | A simulation result under stated assumptions. |
| منظرنامہ | A conditional statement under stated assumptions; never a prediction. |
| Expert input | Expert judgement, recorded with its basis. |
| Candidate | Proposed for a later edition; not yet evidence. |
| Evidence-quality levels (EQL 1 to 5) grade the source behind a value; they are not a score of the subject. | |
A.8How the edition is made, released and corrected
Every edition is built from a sealed evidence cut, reviewed under three keys, signed and deposited before any site shows it as published; corrections go to Nexus Standards as change proposals and feed the next cut.
| مرحلہ | What happens | ماخذ |
|---|---|---|
| 01 Evidence arrives from the pillars | Foundry seals observations and indicator series, Universe hands over after-action and scenario findings, and contributions are screened at every gateway, including this site’s. | |
| 02 The cut is sealed | On the cut date the evidence is pinned under one identifier, so anyone can rebuild the edition from exactly what it was built on. | |
| 03 The edition is assembled | The edition is drafted from its template and content pack. Agents may draft; they never publish and never decide. | |
| 04 The keys turn | At the publisher of record the truth key comes first: every value is checked against its source or stated method before the meaning and capital keys turn. No edition moves on until every key has been turned by a named steward. | |
| 05 The gate opens | A named approver releases one exact digest of the edition; any change after this point is a new version, never a silent edit. | |
| 06 Signed and deposited | The PDF, the web edition and the data bundle are signed together with a manifest and an RO-Crate description, and deposited on Zenodo with a concept and a version DOI. | |
| 07 Published on its desk’s site | Only then does the edition show as published on its desk’s Reports site, and the Collection lists it as a part. | |
| 08 Corrections go to Standards | Method and correction findings go to Nexus Standards as change proposals; citations, corrections and new contributions feed the next evidence cut. |
A teaching model of the process, not a forecast and not a record of any run; dates and counts on this page come from the programme record. Sources: Reports governance at GCRI Canada (2026); Zenodo, repository of record for Reports deposits (2026).
Lifecycle, one state at a time: Draft, Computed, Evidence bound, Reviewed, Approved for release, Published, Corrected, Superseded. This edition is a draft.
A.9Glossary and abbreviations
| اصطلاح | Meaning |
|---|---|
| Baseline Edition | the inaugural annual edition that fixes the reference state for the series |
| WEFH+B | water, energy, food, health and biodiversity, the national nexus core |
| باہمی ربط | a typed dependency through which one system transmits to another |
| Protection gap | the share of losses not covered by insurance |
| Capability ladder | LISTED → EXISTS → ADEQUATE → TESTED → DEMONSTRATED |
| EQL | evidence-quality level, 1–5 |
| Evidence cut | a frozen resolution of exact sources and versions |
| NNC · NLC · NWG | National Nexus Consortium · National Leadership Council · National Working Groups |
| Abbreviation | Expansion |
|---|---|
| ALS | amyotrophic lateral sclerosis |
| BCI | brain-computer interface |
| DBS | deep brain stimulation |
| EFS | early feasibility study |
| FDA | US Food and Drug Administration |
| FTC | US Federal Trade Commission |
| IDE | investigational device exemption |
| MIND | Management of Individuals Neural Data |
| MIIT | Ministry of Industry and Information Technology of China |
| PRIME | Precise Robotically Implanted Brain-Computer Interface study |
| UNESCO | United Nations Educational, Scientific and Cultural Organization |
| WER | word error rate |
A.10Technical annex
| Item | Annex | فہرست مضامین | حیثیت |
|---|---|---|---|
| A.1 | Indicator definitions | the global indicator set, with units and sources | IN THIS EDITION |
| A.2 | Coupling strengths | the twenty-cell matrix and its rationale | IN THIS EDITION |
| A.3 | Scenario specification | SCN-XT20-NDT-01 assumptions and signposts | IN THIS EDITION |
| A.4 | Capability placements | rung evidence for fifteen functions | IN THIS EDITION |
| A.5 | Model diagnostics | first runs and validation | 2027 |
| A.6 | Sensitivity analyses | influence of coupling strengths | 2027 |
| A.7 | Cluster notes | cards for the major clinical interface clusters | 2027 |
| A.8 | Review statements | pass-by-pass review record | AT RELEASE |
A.1 · indicator definition: word error rate
- Construct
- share of decoded words that differ from the words the participant intended to say
- Unit
- percent
- طریقہ
- attempted speech decoded by a trained model from implanted electrode signals, scored against the intended sentences
- ماخذ
- Nature 620 (2023)12
- غیر یقینی صورتحال
- as reported by the authors; not restated here
- Known limits
- one participant per study; sentences and vocabulary set by the researchers
Notes
Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references
- 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03.back
- 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
- 29Mordor Intelligence (ed.), Brain-computer Interface Market Size and Share Analysis (report page updated 3 August 2026; USD 1.27 billion in 2025) and TechSci Research (ed.), Brain Computer Interface Market (report page, January 2026; USD 2.57 billion in 2025). Market-research pages, weak evidence; figures differ about twofold and none is used. Observation year 2025. Accessed 2026-11-05.back
- 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03.back
- 13ClinicalTrials.gov (ed.), PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices, NCT06429735 (record read: recruiting; start 9 January 2024; estimated enrolment 15; updated January 2026; sponsor-supplied entry). National Library of Medicine, Bethesda. Observation year 2026. Accessed 2026-11-03.back
- 26Santhosh, C., Elon Musk’s Neuralink says it has 21 participants enrolled in trials (Reuters, 28 January 2026, read as published by The Star; company statement of 21 participants enrolled worldwide, up from 12 in September 2025). News agency report of a company statement, weak evidence. Reuters, London. Observation year 2026. Accessed 2026-11-05.back
- 15Precision Neuroscience (ed.), company release on FDA 510(k) clearance of the Layer 7 Cortical Interface, 17 April 2025 (release read; vendor announcement, weak evidence: up to 30 days of implantation; 37 patients tested). Precision Neuroscience, New York. Observation year 2025. Accessed 2026-11-03.back
- 27Paradromics (ed.), Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus Brain-Computer Interface (company release of November 2025, read as reposted by BioSpace; IDE approval for an early feasibility study that will initially enrol two participants at three sites). Company statement, weak evidence. Paradromics, Austin. Observation year 2025. Accessed 2026-11-05.back
- 33Genser, J., Damianos, S. and Yuste, R., Safeguarding Brain Data: Assessing the Privacy Practices of Consumer Neurotechnology Companies (report for the Neurorights Foundation, April 2024; policy documents of 30 companies reviewed; no figure used). Neurorights Foundation, New York. Observation year 2024. Accessed 2026-11-05.back
- 25California Legislature (ed.), SB 1223 (Becker), Consumer privacy: sensitive personal information: neural data, Chapter 887, Statutes of 2024, chaptered 28 September 2024 (bill record read on CalMatters Digital Democracy; sponsor release of 27 September 2024: signed by the Governor, in effect 1 January 2025; the legislature page returned an access error). California Legislature, Sacramento. Observation year 2024. Accessed 2026-11-05.back
- 41Spivack, J. and Victory, C., State Neural Data Laws, Summer 2025 (Future of Privacy Forum chart, August 2025; Montana SB 163 adds neurotechnology data to the Genetic Information Privacy Act, effective 1 October 2025; Connecticut SB 1295 adds neural data to sensitive data under its data privacy act, most sections effective 1 July 2026). Secondary compilation; the state texts were not opened. Future of Privacy Forum, Washington. Observation year 2025. Accessed 2026-11-05.back
- 23Wellman, S.M. et al., A materials roadmap to functional neural interface design, Advanced Functional Materials 28(12), 2018 (reference record read; no figures in the abstract). Wiley, Weinheim. Observation year 2018. Accessed 2026-11-03.back
- 32Kaifosh, P., Reardon, T.R. and CTRL-labs at Reality Labs, A generic non-invasive neuromotor interface for human-computer interaction, Nature 645, 702 to 711, 2025 (Crossref record). Springer Nature, London. Observation year 2025. Accessed 2026-11-05.back
- 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03.back
Data appendix
The indicator set with its sources, the source registers, the licences of every kind of material and the formats of the edition.
B.1The indicator set
| Indicator | قدر | Unit | سال | ریاست | ماخذ |
|---|---|---|---|---|---|
| Speech decoding rate, large vocabulary | 62 | words per minute | 2023 | رپورٹ شدہ | 1 |
| Word error rate, 125,000 words | 23.8 | % | 2023 | رپورٹ شدہ | 1 |
| Word error rate, 50 words | 9.1 | % | 2023 | رپورٹ شدہ | 1 |
| Median speech decoding rate | 78 | words per minute | 2023 | رپورٹ شدہ | 2 |
| Median word error rate | 25 | % | 2023 | رپورٹ شدہ | 2 |
| Accuracy beyond eight months, 125,000 words | 97.5 | % | 2023 | رپورٹ شدہ | 3 |
| Electrodes in the accuracy study | 256 | electrodes | 2023 | رپورٹ شدہ | 3 |
| Handwriting decoding rate | 90 | characters per minute | 2021 | رپورٹ شدہ | 6 |
| Participants in the inner speech study | 4 | participants | 2025 | رپورٹ شدہ | 5 |
| Participants in the endovascular study | 5 | participants | 2025 | رپورٹ شدہ | 8 |
| Channels in the endovascular array | 16 | channels | 2025 | رپورٹ شدہ | 8 |
| Estimated enrolment in PRIME | 15 | participants | 2026 | رپورٹ شدہ | 13 |
| Participants implanted, company statement | 5 | participants | 2025 | رپورٹ شدہ | 20 |
| Neuralink round | 650 | USD million | 2025 | رپورٹ شدہ | 20 |
| FTC study authorisation in the MIND Act | 10 | USD million | 2025 | رپورٹ شدہ | 11 |
| Maximum implantation duration in the cleared array | 30 | days | 2025 | رپورٹ شدہ | 15 |
B.2Global source register
The governed source set behind this edition. Each source keeps its authority, coverage, cadence and role; categories describe origin, not truth.
Domains bound by the register
- INF
- DAT
- HLT
- FIN
- GOV
- BIO
- TRD
- MIN
- ENE
- AIC
| ماخذ | Category | احاطہ | Period | Cadence | کردار |
|---|---|---|---|---|---|
| Willett et al. in Nature1 | peer-reviewed journal | one participant | 2023 | one-off | speech decoding |
| Metzger et al. in Nature2 | peer-reviewed journal | one participant | 2023 | one-off | speech and avatar |
| Card et al. record3 | preprint server record | one participant | 2023 | one-off | accuracy |
| Kunz et al. in Cell5 | peer-reviewed journal | four participants | 2025 | one-off | inner speech |
| Lorach et al. in Nature7 | peer-reviewed journal | one participant | 2023 | one-off | brain-spine interface |
| Chetty et al.8 | preprint server | five participants | 2025 | one-off | endovascular |
| FDA guidance9 | national regulator | US | 2021 | one-off | testing |
| UNESCO page10 | intergovernmental body | global | 2025 | one-off | ethics |
| رجسٹری کا اندراج13 | trial registry | one study | 2026 | continuous | enrolment |
| Chinese implementation opinion, translated16 | translation of a ministry text | چین | 2025 | one-off | targets |
B.3Regional reading, neurotechnology across ten clusters
Regional plates follow with the regional editions. This page gives the regional reading of neurotechnology and neural data in table form and ranks no region.
| خطہ | Principal hazards | Systems most exposed | Baseline evidence |
|---|---|---|---|
| شمالی امریکہ | clinical trials; federal guidance; state neural data laws | devices, data law | FDA9; Colorado14; Senate11 |
| جنوبی امریکہ | constitutional neurorights in Chile | data law | Chilean sources1718 |
| یورپ | medical device rules and research programmes | regulation | regional evidence (not bound) |
| Eurasia | research programmes | research | regional evidence (not bound) |
| مشرق وسطیٰ اور شمالی افریقہ | no evidence bound | not bound | regional evidence (not bound) |
| افریقہ | access and skills | workforce | regional evidence (not bound) |
| جنوبی ایشیا | no evidence bound | not bound | regional evidence (not bound) |
| مشرقی ایشیا | industrial policy targets for 2027 and 2030 | industry policy | Chinese opinion16 |
| ASEAN | no evidence bound | not bound | regional evidence (not bound) |
| Oceania-Pacific | no evidence bound | not bound | regional evidence (not bound) |
B.4Cluster card: speech neuroprosthesis research network
- speech
- intracortical arrays
- single participants
- inner speech
- Systems in view
- implanted arrays, decoders, clinical teams, participants with paralysis
- Defining events
- two Nature papers of August 202312
- Couplings
- INF → HLT clinical benefit; INF → DAT inner speech
- Capability evidence
- long-term accuracy and inner speech safeguards reported35
- Gaps
- participants beyond one or four; home use; durability
- Agenda items
- N-04 · N-05
Speech decoders reached 62 and 78 words per minute in single participants with paralysis [1] [2].
CLINIC
Speech from attempted speaking
Imagined sentences were decoded in four participants, and the authors propose safeguards against unintended decoding [5].
DATA
Inner speech
Accuracy of 97.5% beyond eight months was reported for one participant; drift remains a studied problem [3] [22].
DURABILITY
Months after implantation
B.5How countries appear in the neurotechnology edition
Countries enter the neurotechnology edition through the readiness chapters of their own national editions, on one card grammar. They are read against peer distributions and thresholds, never ranked.
| Card field | What it shows | ماخذ |
|---|---|---|
| WEFH+B state | each core system against peer distribution bands | national edition |
| Couplings | the national dependency matrix | national edition |
| Risk objects | the national risk portfolio | national edition |
| Capability rungs | the national capability ladder | national edition |
| Evidence age | oldest and newest source dates | national source register |
Editions in the 2026 Baseline programme
countries and unions
clusters
flagship and sector
technology reports
How to read a country card
- Each system is shown against the distribution of its peers, with thresholds where they exist
- Couplings and risk objects come from the country’s own national edition
- Capability rungs record evidence, not a judgement of institutions
- Evidence age is printed, so older national data are visible as such
| Wave | Countries and unions | ریاست |
|---|---|---|
| W0 | کینیڈا | ISSUED |
| W1 | United States, United Kingdom, France, Germany, Italy, Japan, European Union, Switzerland | PLANNED |
| W2 | Mexico, Brazil, Argentina, Türkiye, Russian Federation, Saudi Arabia, United Arab Emirates, South Africa, Senegal, Kenya, African Union, India, China, Republic of Korea, Indonesia, Singapore, Australia | PLANNED |
B.6لائسنس
| Material | لائسنس |
|---|---|
| Text | CC BY 4.0 |
| ڈیٹا | on the licence of each source; Nexus tables CC BY 4.0 |
| Figures | Nexus figures CC BY 4.0; third-party as credited |
| نقشے | boundary source and licence printed on each plate |
| Metadata | CC0 1.0, as Zenodo publishes it |
| Third-party data, figures and text | The source’s own licence, credited where it is used; never relicensed |
| Nexus-authored text, tables and figures: CC BY 4.0 (SPDX CC-BY-4.0). Map plates print their boundary source and licence. | |
B.7Formats and provenance
| Format | Kind | ریاست | یہ کیا ہے | Identifier |
|---|---|---|---|---|
| Web edition | HTML | On this site | Draft in stewardship review; every value resolves to its source. | NR-XTECH-NEURO-GLOBAL-2026-BASELINE-v1.0.0 |
| Print edition | At release | A4 portrait · screen, print and archival PDF, signed with the web edition at release. | NR-XTECH-NEURO-GLOBAL-2026-BASELINE-v1.0.0 | |
| Indicator data | CSV · JSON | On this site | 16 indicators with unit, year, status and source; the machine-readable copy ships with the evidence bundle at release. | NR-XTECH-NEURO-GLOBAL-2026-BASELINE data release v1 |
| Figures | SVG · PNG | On this site | 4 on the web edition: headline figure, figure 1.3, coupling instrument, capability ladder. | FIG-XTECH-NEURO-GLOBAL-2026-BASELINE-* |
| Slides | Not recorded | No slide deck is recorded for this edition. | ||
| Evidence brief | HTML · PDF | Not recorded | No evidence brief is recorded for this edition. | |
| Dataset with DOI | DataCite | At release | Concept and version DOI are minted at deposit; none is recorded yet. |
ماخذ کا سراغ
- Edition pack
- The edition’s content pack (JSON), from which the print and web editions are built
- Evidence cut
- DC-XTECH-NEURO-GLOBAL-2026-B0, closed 30 September 2026
- Reproducibility
- sourced values cited; analytical values reproducible from stated parameters
- Self-check
- 14 of 23 at evidence close; a fail on any item blocks release
- جائزہ
- five passes scheduled before release (in Annex C)
- Publisher of record
- GCRI for the Nexus Consortium
- تصحیحات
- Registry correction pathway; upheld corrections are published as notices with a new version
Notes
Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references
- 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03.back
- 6Willett, F.R., Avansino, D.T., Hochberg, L.R., Henderson, J.M. and Shenoy, K.V., High-performance brain-to-text communication via handwriting, Nature 593(7858), 249 to 254, published online 12 May 2021 (reference record read: 90 characters per minute; 94.1% raw online accuracy). Springer Nature, London. Observation year 2021. Accessed 2026-11-03.back
- 5Kunz, E.M. et al., Inner speech in motor cortex and implications for speech neuroprostheses, Cell 188(17), 4658 to 4673, published online 14 August 2025 (reference record read: four participants). Cell Press, Cambridge MA. Observation year 2025. Accessed 2026-11-03.back
- 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03.back
- 13ClinicalTrials.gov (ed.), PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices, NCT06429735 (record read: recruiting; start 9 January 2024; estimated enrolment 15; updated January 2026; sponsor-supplied entry). National Library of Medicine, Bethesda. Observation year 2026. Accessed 2026-11-03.back
- 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
- 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03.back
- 15Precision Neuroscience (ed.), company release on FDA 510(k) clearance of the Layer 7 Cortical Interface, 17 April 2025 (release read; vendor announcement, weak evidence: up to 30 days of implantation; 37 patients tested). Precision Neuroscience, New York. Observation year 2025. Accessed 2026-11-03.back
- 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 9US Food and Drug Administration (ed.), Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation: Non-clinical Testing and Clinical Considerations, final guidance, May 2021 (guidance page read). Center for Devices and Radiological Health, Silver Spring. Observation year 2021. Accessed 2026-11-03.back
- 10UNESCO (ed.), Recommendation on the Ethics of Neurotechnology (page read: adopted November 2025 at the 43rd session of the General Conference; mandate entrusted by 194 Member States in 2023; the page states no neural data provisions). United Nations Educational, Scientific and Cultural Organization, Paris. Observation year 2025. Accessed 2026-11-03.back
- 16Ministry of Industry and Information Technology and six other bodies (eds.), Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry, MIIT (2025) No. 164, 23 July 2025, English translation by the Center for Security and Emerging Technology, 18 December 2025 (translation page read). Georgetown University, Washington. Observation year 2025. Accessed 2026-11-03.back
- 14Colorado General Assembly (ed.), HB24-1058 Protect Privacy of Biological Data (bill page read: signed 17 April 2024; effective 7 August 2024). Colorado General Assembly, Denver. Observation year 2024. Accessed 2026-11-03.back
- 17Cornejo-Plaza, M.I., Cippitani, R. and Pasquino, V., Chilean Supreme Court ruling on the protection of brain activity: neurorights, personal data protection, and neurodata, Frontiers in Psychology 15, 27 February 2024 (reference record read). Frontiers Media, Lausanne. Observation year 2024. Accessed 2026-11-03.back
- 18Lee, B.H., Even Chile neurorights leave inferred mental data in a gray zone, Stanford Law School Law and Biosciences Blog, 27 April 2026 (blog page read; commentary, not a legal text). Stanford University, Stanford. Observation year 2026. Accessed 2026-11-03.back
References and record
Every source the edition rests on, the publication record, the corrections log and the open record.
C.144 sources
NR-CIT-1, editor first. A DOI is linked where the source has one; Nexus records carry a UNI once the catalogue allocates it (NS-1).
- 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 8
- 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 8
- 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 6, chapter 8
- 4Wairagkar, M. et al., An instantaneous voice synthesis neuroprosthesis, bioRxiv preprint, 19 August 2024 (preprint record read: 256 microelectrodes, one participant with ALS; no quantitative scores in the abstract; the record notes Nature 644(8075), 145 to 152, 2025). Cold Spring Harbor Laboratory, New York. Observation year 2024. Accessed 2026-11-03. Cited in chapter 6, chapter 8
- 5Kunz, E.M. et al., Inner speech in motor cortex and implications for speech neuroprostheses, Cell 188(17), 4658 to 4673, published online 14 August 2025 (reference record read: four participants). Cell Press, Cambridge MA. Observation year 2025. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 7
- 6Willett, F.R., Avansino, D.T., Hochberg, L.R., Henderson, J.M. and Shenoy, K.V., High-performance brain-to-text communication via handwriting, Nature 593(7858), 249 to 254, published online 12 May 2021 (reference record read: 90 characters per minute; 94.1% raw online accuracy). Springer Nature, London. Observation year 2021. Accessed 2026-11-03. Cited in chapter 6, chapter 8
- 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 8
- 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03. Cited in the summary, chapter 2, chapter 3, chapter 4, chapter 6, chapter 8
- 9US Food and Drug Administration (ed.), Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation: Non-clinical Testing and Clinical Considerations, final guidance, May 2021 (guidance page read). Center for Devices and Radiological Health, Silver Spring. Observation year 2021. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 4, chapter 6, chapter 8
- 10UNESCO (ed.), Recommendation on the Ethics of Neurotechnology (page read: adopted November 2025 at the 43rd session of the General Conference; mandate entrusted by 194 Member States in 2023; the page states no neural data provisions). United Nations Educational, Scientific and Cultural Organization, Paris. Observation year 2025. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 7, chapter 8
- 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 8
- 12US Senate Committee on Commerce, Science, and Transportation (ed.), release on the introduction of the MIND Act, 24 September 2025 (release read: names Colorado, California, Montana and Connecticut as states with neural data laws). US Senate, Washington. Observation year 2025. Accessed 2026-11-03. Cited in chapter 2, chapter 3, chapter 4, chapter 6, chapter 8
- 13ClinicalTrials.gov (ed.), PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices, NCT06429735 (record read: recruiting; start 9 January 2024; estimated enrolment 15; updated January 2026; sponsor-supplied entry). National Library of Medicine, Bethesda. Observation year 2026. Accessed 2026-11-03. Cited in chapter 2, chapter 3, chapter 4, chapter 8
- 14Colorado General Assembly (ed.), HB24-1058 Protect Privacy of Biological Data (bill page read: signed 17 April 2024; effective 7 August 2024). Colorado General Assembly, Denver. Observation year 2024. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 5, chapter 6, chapter 8
- 15Precision Neuroscience (ed.), company release on FDA 510(k) clearance of the Layer 7 Cortical Interface, 17 April 2025 (release read; vendor announcement, weak evidence: up to 30 days of implantation; 37 patients tested). Precision Neuroscience, New York. Observation year 2025. Accessed 2026-11-03. Cited in chapter 2, chapter 4, chapter 6, chapter 7, chapter 8
- 16Ministry of Industry and Information Technology and six other bodies (eds.), Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry, MIIT (2025) No. 164, 23 July 2025, English translation by the Center for Security and Emerging Technology, 18 December 2025 (translation page read). Georgetown University, Washington. Observation year 2025. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 4, chapter 6, chapter 8
- 17Cornejo-Plaza, M.I., Cippitani, R. and Pasquino, V., Chilean Supreme Court ruling on the protection of brain activity: neurorights, personal data protection, and neurodata, Frontiers in Psychology 15, 27 February 2024 (reference record read). Frontiers Media, Lausanne. Observation year 2024. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 5, chapter 8
- 18Lee, B.H., Even Chile neurorights leave inferred mental data in a gray zone, Stanford Law School Law and Biosciences Blog, 27 April 2026 (blog page read; commentary, not a legal text). Stanford University, Stanford. Observation year 2026. Accessed 2026-11-03. Cited in the summary, chapter 2, chapter 4, chapter 6, chapter 8
- 19Szoszkiewicz, L. and Yuste, R., Mental privacy: navigating risks, rights and regulation, EMBO Reports 26(14), 3469 to 3473, published online 25 June 2025 (reference record read; no abstract beyond the subtitle). Springer Nature, London. Observation year 2025. Accessed 2026-11-03. Cited in chapter 6, chapter 8
- 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 7, chapter 8
- 21Bublitz, C. et al., A moratorium on implantable non-medical neurotech until effects on the mind are properly understood, Neuroethics 18(3), article 46, 2025 (reference record read: proposes a mental impact assessment, a moratorium and a ban for children). Springer, Dordrecht. Observation year 2025. Accessed 2026-11-03. Cited in chapter 6, chapter 8
- 22Ma, X. et al., Using adversarial networks to extend brain computer interface decoding accuracy over time, eLife 12, e84296, 2023 (reference record read). eLife Sciences, Cambridge. Observation year 2023. Accessed 2026-11-03. Cited in chapter 1, chapter 4, chapter 6, chapter 8
- 23Wellman, S.M. et al., A materials roadmap to functional neural interface design, Advanced Functional Materials 28(12), 2018 (reference record read; no figures in the abstract). Wiley, Weinheim. Observation year 2018. Accessed 2026-11-03. Cited in chapter 6, chapter 8
- 24Feng, Y. et al., Brain-computer interfaces: the dawn of a new era in disease treatment, Exploration 6(3), 2026 (reference record read: electrode biocompatibility and signal resolution named as challenges). Wiley, Beijing. Observation year 2026. Accessed 2026-11-03. Cited in chapter 1, chapter 4, chapter 6, chapter 8
- 25California Legislature (ed.), SB 1223 (Becker), Consumer privacy: sensitive personal information: neural data, Chapter 887, Statutes of 2024, chaptered 28 September 2024 (bill record read on CalMatters Digital Democracy; sponsor release of 27 September 2024: signed by the Governor, in effect 1 January 2025; the legislature page returned an access error). California Legislature, Sacramento. Observation year 2024. Accessed 2026-11-05. Cited in chapter 6, chapter 8
- 26Santhosh, C., Elon Musk’s Neuralink says it has 21 participants enrolled in trials (Reuters, 28 January 2026, read as published by The Star; company statement of 21 participants enrolled worldwide, up from 12 in September 2025). News agency report of a company statement, weak evidence. Reuters, London. Observation year 2026. Accessed 2026-11-05. Cited in chapter 8
- 27Paradromics (ed.), Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus Brain-Computer Interface (company release of November 2025, read as reposted by BioSpace; IDE approval for an early feasibility study that will initially enrol two participants at three sites). Company statement, weak evidence. Paradromics, Austin. Observation year 2025. Accessed 2026-11-05. Cited in chapter 4, chapter 8
- 28Medtronic (ed.), Medtronic receives FDA approval for BrainSense Adaptive DBS technology (company release republished by News-Medical, 3 March 2025; FDA approval of adaptive deep brain stimulation and the BrainSense Electrode Identifier for Parkinson disease). Company statement, weak evidence. Medtronic, Dublin. Observation year 2025. Accessed 2026-11-05. Cited in chapter 8
- 29Mordor Intelligence (ed.), Brain-computer Interface Market Size and Share Analysis (report page updated 3 August 2026; USD 1.27 billion in 2025) and TechSci Research (ed.), Brain Computer Interface Market (report page, January 2026; USD 2.57 billion in 2025). Market-research pages, weak evidence; figures differ about twofold and none is used. Observation year 2025. Accessed 2026-11-05. Cited in the summary, chapter 1, chapter 6, chapter 8
- 30Synchron (ed.), Synchron Raises USD 200 Million Series D to Advance Brain-Computer Interface Technology (Business Wire release as reproduced by I-Connect007, 7 November 2025; total funding USD 345 million). Company statement, weak evidence; no figure used. Synchron, New York. Observation year 2025. Accessed 2026-11-05. Cited in chapter 4, chapter 6, chapter 8
- 31OECD (ed.), Recommendation of the Council on Responsible Innovation in Neurotechnology, OECD/LEGAL/0457, adopted 11 December 2019 (instrument text opened). Organisation for Economic Co-operation and Development, Paris. Observation year 2019. Accessed 2026-11-05. Cited in chapter 4, chapter 6, chapter 8
- 32Kaifosh, P., Reardon, T.R. and CTRL-labs at Reality Labs, A generic non-invasive neuromotor interface for human-computer interaction, Nature 645, 702 to 711, 2025 (Crossref record). Springer Nature, London. Observation year 2025. Accessed 2026-11-05. Cited in chapter 8
- 33Genser, J., Damianos, S. and Yuste, R., Safeguarding Brain Data: Assessing the Privacy Practices of Consumer Neurotechnology Companies (report for the Neurorights Foundation, April 2024; policy documents of 30 companies reviewed; no figure used). Neurorights Foundation, New York. Observation year 2024. Accessed 2026-11-05. Cited in chapter 6, chapter 8
- 34Yuste, R. et al., Four ethical priorities for neurotechnologies and AI, Nature 551, 159 to 163, 2017 (Crossref record). Springer Nature, London. Observation year 2017. Accessed 2026-11-05. Cited in chapter 6, chapter 8
- 35Ienca, M. and Andorno, R., Towards new human rights in the age of neuroscience and neurotechnology, Life Sciences, Society and Policy 13, 5, 2017 (Crossref record). Springer, Berlin. Observation year 2017. Accessed 2026-11-05. Cited in chapter 6, chapter 8
- 36Hochberg, L.R. et al., Neuronal ensemble control of prosthetic devices by a human with tetraplegia, Nature 442, 164 to 171, 2006 (Crossref record). Springer Nature, London. Observation year 2006. Accessed 2026-11-05. Cited in chapter 6
- 37Collinger, J.L. et al., High-performance neuroprosthetic control by an individual with tetraplegia, The Lancet 381, 557 to 564, 2013 (Crossref record). Elsevier, London. Observation year 2013. Accessed 2026-11-05. Cited in chapter 6
- 38Moses, D.A. et al., Neuroprosthesis for decoding speech in a paralyzed person with anarthria, New England Journal of Medicine 385, 217 to 227, 2021 (Crossref record). Massachusetts Medical Society, Waltham. Observation year 2021. Accessed 2026-11-05. Cited in chapter 6
- 39European Parliament and Council, Regulation (EU) 2017/745 of 5 April 2017 on medical devices, Annex XVI point 6 (equipment intended for brain stimulation that applies electrical currents or magnetic or electromagnetic fields that penetrate the cranium). Official Journal of the European Union L 117, 5 May 2017, Luxembourg. Observation year 2017. Accessed 2026-11-05. Cited in chapter 6, chapter 8
- 40ISO (ed.), ISO 14708-3:2017 Implants for surgery, Active implantable medical devices, Part 3: Implantable neurostimulators (ISO open-data deliverables record: published 12 April 2017; current, confirmed). International Organization for Standardization, Geneva. Observation year 2017. Accessed 2026-11-05. Cited in chapter 4, chapter 6, chapter 8
- 41Spivack, J. and Victory, C., State Neural Data Laws, Summer 2025 (Future of Privacy Forum chart, August 2025; Montana SB 163 adds neurotechnology data to the Genetic Information Privacy Act, effective 1 October 2025; Connecticut SB 1295 adds neural data to sensitive data under its data privacy act, most sections effective 1 July 2026). Secondary compilation; the state texts were not opened. Future of Privacy Forum, Washington. Observation year 2025. Accessed 2026-11-05. Cited in chapter 6, chapter 8
- 42Carey (ed.), Ley N 21.383: publican reforma constitucional para establecer el desarrollo cientifico y tecnologico al servicio de las personas (client alert, 3 November 2021; Law 21.383 published in the Diario Oficial on 25 October 2021; adds a final paragraph to Article 19 No. 1 on protecting brain activity and the information derived from it). Law firm summary; the official text page did not load. Carey, Santiago. Observation year 2021. Accessed 2026-11-05. Cited in chapter 6, chapter 8
- 43European Parliament and Council, Regulation (EU) 2024/1689 of 13 June 2024 laying down harmonised rules on artificial intelligence (Artificial Intelligence Act), Article 5(1)(f) on AI systems to infer emotions in the workplace and education institutions, except for medical or safety reasons. Official Journal of the European Union, L series, 12 July 2024, Luxembourg. Observation year 2024. Accessed 2026-11-05. Cited in chapter 6, chapter 8
- 44Holt, K., Neuralink says the FDA designated its Blindsight implant as a breakthrough device (Engadget, 18 September 2024; company statement as reported). Trade press reporting a vendor announcement, weak evidence. Engadget, New York. Observation year 2024. Accessed 2026-11-05. Cited in chapter 8
C.2Publication record
Publication
- Title
- Exponential Technology Report 2026: Neurotechnology and Human–Machine Interfaces, Baseline Edition
- سلسلہ
- Reports · Exponential Technology Series XT-20
- ایڈیشن
- Baseline Edition 2026 · inaugural annual
- ورژن
- v1.0.0 · draft for stewardship review
- Publication ID
- NR-XTECH-NEURO-GLOBAL-2026-BASELINE-v1.0.0
- شواہد کی آخری تاریخ
- 30 September 2026
- Publication date
- October 2026
- DOI
- concept and version DOI at deposit
ناشر
- Publisher of record
- The Global Centre for Risk and Innovation (GCRI), for the Nexus Consortium
- مقام
- Toronto
- Editor
- Saeed Valadbaygi, Chief Steward and Managing Editor
- Stewards
- GCRI · technical truth · GRF · public meaning · GRA · capital meaning
- لائسنس
- text CC BY 4.0; data on the terms of each source
- Copyright
- © 2026 GCRI · Nexus Consortium
- Language
- English (en-GB) source edition
- Correspondence
- Registry correction pathway · editorial office
Colophon
- Format
- A4 portrait · screen, print and archival PDF
- Typefaces
- Space Grotesk (display) · Geist (text) · IBM Plex Sans Italic (standfirsts) · IBM Plex Mono (data)
- Design standard
- Reports Foundational Edition, Volume I, Part VII
- رسائی پذیری
- tagged PDF and HTML targets; text alternatives for every figure
- Production
- Reports editorial team, GCRI
Release path for this version
| مرحلہ | What happens | When |
|---|---|---|
| مسودہ | editorial self-check complete at evidence close | October 2026 |
| Steward review | five passes on the exact draft (keys T · M · F · N) | Q4 2026 |
| Approval | publication authority approves the exact digest | before release |
| Deposit | concept and version DOI minted; registry pointer set | at release |
| جانشینی | the 2027 neurotechnology edition reports changes against this baseline | 2027 |
- Current version
- v1.0.0 draft, stewardship review
- Previous edition
- none, first edition of the series
- Next edition
- NR-XTECH-NEURO-GLOBAL-2027-v1.0.0
- Latest version
- resolve the concept DOI or the registry record
- Correction route
- Registry correction pathway
- Notice types
- erratum · addendum · supersession · withdrawal
C.3Corrections log
0correction notices. No edition has been released yet, so none can be corrected; the log below lists each edition’s current version.
| ایڈیشن | ورژن | Date | ریاست | تبدیلی | Notice |
|---|---|---|---|---|---|
| XT-20 | NR-XTECH-NEURO-GLOBAL-2026-BASELINE-v1.0.0 | October 2026 | مسودہ | Baseline Edition 2026, inaugural annual edition, | None |
Notice types: erratum, addendum, supersession, withdrawal. A correction is a new version with a published notice; the earlier version stays resolvable, and no edition is ever edited in silence.
C.4Open record
This edition’s open record
- Publication ID
- NR-XTECH-NEURO-GLOBAL-2026-BASELINE-v1.0.0
- Desk identifier and series alias
- NR-GCRI-XT-20-2026-BASELINE-v1.0.0 · NR-XTC-XT-20-2026-BL
- Collection
- NR-COL-2026-BASELINE (IsPartOf at deposit)
- DOI
- Concept and version DOI at deposit, on Zenodo with DataCite metadata
- Versions
- Each correction is a new version (isNewVersionOf); the concept DOI resolves to the latest
- Bundle
- RO-Crate 1.2 with CITATION.cff, CodeMeta and PROV-O provenance; a signed manifest
- لائسنس
- CC BY 4.0 (SPDX CC-BY-4.0) for original material; metadata CC0 1.0
Credit and identity
- ORCID
- Your iD in the deposit and the contribution record; DataCite can then add the work to your ORCID record
- ROR
- Your organisation by its ROR identifier, never by a typed name alone
- CRediT
- Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualisation, Writing, review and editing
- Account
- None needed to contribute; never a password
Find and follow
Search the open indexes for Neurotechnology and Human–Machine Interfaces; software is cited by its SWHID from Software Heritage, and a quantified scenario run is preregistered on OSF before it is run. Annotation is your choice: Hypothesis opens this page in its own viewer.
Mirrors and harvest
The DOI is canonical. At release each signed bundle is also given an IPFS content identifier and a bloxberg anchor as mirrors; both are listed in the record once they exist. Zenodo exposes every record over OAI-PMH, and reviews and endorsements can arrive through COAR Notify where the repository supports it.
{
"metadata": {
"resource_type": {
"id": "dataset"
},
"title": "Evidence on Neurotechnology and Human–Machine Interfaces for Nexus Reports",
"publication_date": "YYYY-MM-DD",
"creators": [
{
"person_or_org": {
"type": "personal",
"family_name": "Your family name",
"given_name": "Your given name",
"identifiers": [
{
"scheme": "orcid",
"identifier": "0000-0000-0000-0000"
}
]
},
"affiliations": [
{
"id": "ROR identifier of your organisation"
}
]
}
],
"description": "What it is, where its record is kept and how it bears on Exponential Technology Report 2026: Neurotechnology and Human–Machine Interfaces.",
"rights": [
{
"id": "cc-by-4.0"
}
],
"subjects": [
{
"subject": "Nexus Reports"
},
{
"subject": "Neurotechnology and Human–Machine Interfaces"
},
{
"subject": "Exponential Technology Report · XT-20"
}
],
"related_identifiers": [
{
"identifier": "https://therisk.global/nexus-reports/editions/xt-20/",
"scheme": "url",
"relation_type": {
"id": "issupplementto"
},
"resource_type": {
"id": "publication-report"
}
}
],
"version": "1.0.0"
},
"custom_fields": {},
"access": {
"record": "public",
"files": "public"
},
"files": {
"enabled": true
},
"parent": {
"communities": {
"default": "nexusreports"
}
}
}C.5Where this edition sits among the six pillars
Foundry seals the evidence and Universe tests it; Reports publishes it; Standards takes its corrections and Academy teaches from it.
- F03 Sealed observations and indicator series Foundry Sealed observations and indicator series behind a profile (closeout).
- F04 After-action and scenario findings for Universe After-action and scenario findings for chapters 10 and 13 (after action review).
- F05 National Portfolio movement for chapter Foundry National Portfolio movement for chapter 11 (after action review).
- Applied in editions Standards Nexus Standards: applied in editions.
- XT-20 edition Reports Neurotechnology and Human–Machine Interfaces 2026, published in every format with its sources, citation and corrections.
- F06 Method and correction findings as change Standards Method and correction findings as change proposals (correction).
- F12 Q4 synthesis informs the next-year Universe Q4 synthesis informs the next-year mandate (renewal).
- Taught in the open Academy Risk Academy: taught in the open.
What Foundry and Universe hand to this edition, and what it hands to Standards, Universe and Academy. From the programme spine; XT-20 is a drafted Baseline Edition, so these handoffs run from its first operational quarter.
| Handoff | Between | What crosses, and when |
|---|---|---|
| F03 | Foundry to Reports | Sealed observations and indicator series behind a profile (closeout). |
| F04 | Universe to Reports | After-action and scenario findings for chapters 10 and 13 (after action review). |
| F05 | Foundry to Reports | National Portfolio movement for chapter 11 (after action review). |
| Ring | Nexus Standards to Reports | Nexus Standards: applied in editions. |
| F06 | Reports to Nexus Standards | Method and correction findings as change proposals (correction). |
| F12 | Reports to Universe | Q4 synthesis informs the next-year mandate (renewal). |
| Ring | Reports to Risk Academy | Risk Academy: taught in the open. |
